

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Recent advances in the management of ventricular... | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/6-1027/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/6-1027" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Recent advances in the management of ventricular tachyarrhythmias" />
    
            <meta name="og:title" content="F1000Research Article: Recent advances in the management of ventricular tachyarrhythmias.">
            <meta name="og:description" content="Read the latest article version by Syeda Atiqa Batul, Brian Olshansky, John D. Fisher, Rakesh Gopinathannair, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="12086">
            <meta name="article-id" content="11202">
            <meta name="dc.title" content="Recent advances in the management of ventricular tachyarrhythmias">
            <meta name="dc.description" content="Ventricular arrhythmias are an important cause of cardiovascular morbidity and mortality, particularly in those with structural heart disease, inherited cardiomyopathies, and channelopathies. The goals of ventricular arrhythmia management include symptom relief, improving quality of life, reducing implantable cardioverter defibrillator shocks, preventing deterioration of left ventricular function, reducing risk of arrhythmic death, and potentially improving overall survival. Guideline-directed medical therapy and implantable cardioverter defibrillator implantation remain the mainstay of therapy to prevent sudden cardiac death in patients with ventricular arrhythmias in the setting of structural heart disease. Recent advances in imaging modalities and commercial availability of genetic testing panels have enhanced our mechanistic understanding of the disease processes and, along with significant progress in catheter-based ablative therapies, have enabled a tailored and more effective management of drug-refractory ventricular arrhythmias. Several gaps in our knowledge remain and require further research. In this article, we review the recent advances in the diagnosis and management of ventricular arrhythmias.">
            <meta name="dc.subject" content="Ventricular Arrhythmias, cardiomyopathy, catheter ablation, implantable cardioverter-defibrillator">
            <meta name="dc.creator" content="Batul, Syeda Atiqa">
            <meta name="dc.creator" content="Olshansky, Brian">
            <meta name="dc.creator" content="Fisher, John D.">
            <meta name="dc.creator" content="Gopinathannair, Rakesh">
            <meta name="dc.date" content="2017/06/29">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.11202.1">
            <meta name="dc.source" content="F1000Research 2017 6:1027">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="Ventricular Arrhythmias">
            <meta name="prism.keyword" content="cardiomyopathy">
            <meta name="prism.keyword" content="catheter ablation">
            <meta name="prism.keyword" content="implantable cardioverter-defibrillator">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2017/06/29">
            <meta name="prism.volume" content="6">
            <meta name="prism.number" content="1027">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.11202.1">
            <meta name="prism.url" content="https://f1000research.com/articles/6-1027">
            <meta name="citation_title" content="Recent advances in the management of ventricular tachyarrhythmias">
            <meta name="citation_abstract" content="Ventricular arrhythmias are an important cause of cardiovascular morbidity and mortality, particularly in those with structural heart disease, inherited cardiomyopathies, and channelopathies. The goals of ventricular arrhythmia management include symptom relief, improving quality of life, reducing implantable cardioverter defibrillator shocks, preventing deterioration of left ventricular function, reducing risk of arrhythmic death, and potentially improving overall survival. Guideline-directed medical therapy and implantable cardioverter defibrillator implantation remain the mainstay of therapy to prevent sudden cardiac death in patients with ventricular arrhythmias in the setting of structural heart disease. Recent advances in imaging modalities and commercial availability of genetic testing panels have enhanced our mechanistic understanding of the disease processes and, along with significant progress in catheter-based ablative therapies, have enabled a tailored and more effective management of drug-refractory ventricular arrhythmias. Several gaps in our knowledge remain and require further research. In this article, we review the recent advances in the diagnosis and management of ventricular arrhythmias.">
            <meta name="citation_description" content="Ventricular arrhythmias are an important cause of cardiovascular morbidity and mortality, particularly in those with structural heart disease, inherited cardiomyopathies, and channelopathies. The goals of ventricular arrhythmia management include symptom relief, improving quality of life, reducing implantable cardioverter defibrillator shocks, preventing deterioration of left ventricular function, reducing risk of arrhythmic death, and potentially improving overall survival. Guideline-directed medical therapy and implantable cardioverter defibrillator implantation remain the mainstay of therapy to prevent sudden cardiac death in patients with ventricular arrhythmias in the setting of structural heart disease. Recent advances in imaging modalities and commercial availability of genetic testing panels have enhanced our mechanistic understanding of the disease processes and, along with significant progress in catheter-based ablative therapies, have enabled a tailored and more effective management of drug-refractory ventricular arrhythmias. Several gaps in our knowledge remain and require further research. In this article, we review the recent advances in the diagnosis and management of ventricular arrhythmias.">
            <meta name="citation_keywords" content="Ventricular Arrhythmias, cardiomyopathy, catheter ablation, implantable cardioverter-defibrillator">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Syeda Atiqa Batul">
            <meta name="citation_author_institution" content="Arrhythmia Division, Montefiore Medical Center, Bronx, New York, USA">
            <meta name="citation_author" content="Brian Olshansky">
            <meta name="citation_author_institution" content="University of Iowa Hospitals and Clinics, Iowa City, USA">
            <meta name="citation_author" content="John D. Fisher">
            <meta name="citation_author_institution" content="Arrhythmia Division, Montefiore Medical Center, Bronx, New York, USA">
            <meta name="citation_author" content="Rakesh Gopinathannair">
            <meta name="citation_author_institution" content="Division of Cardiovascular Medicine, University of Louisville School of Medicine, Louisville, USA">
            <meta name="citation_publication_date" content="2017/06/29">
            <meta name="citation_volume" content="6">
            <meta name="citation_publication_number" content="1027">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.11202.1">
            <meta name="citation_firstpage" content="1027">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/6-1027/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/6-1027.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=12086 /> <input type=hidden id=articleId name=articleId value=11202 /> <input type=hidden id=xmlUrl value="/articles/6-1027/v1/xml"/> <input type=hidden id=xmlFileName value="-6-1027-v1.xml"> <input type=hidden id=article_uuid value=8bc7d05f-e5bf-4f1b-9ebe-05a6057ff9d7 /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Recent advances in the management of ventricular tachyarrhythmias"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.11202.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.11202.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/6-1027"
  },
  "headline": "Recent advances in the management of ventricular tachyarrhythmias",
  "datePublished": "2017-06-29T15:01:33",
  "dateModified": "2017-06-29T15:01:33",
  "author": [
    {
      "@type": "Person",
      "name": "Syeda Atiqa Batul"
    },    {
      "@type": "Person",
      "name": "Brian Olshansky"
    },    {
      "@type": "Person",
      "name": "John D. Fisher"
    },    {
      "@type": "Person",
      "name": "Rakesh Gopinathannair"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "Ventricular arrhythmias are an important cause of cardiovascular morbidity and mortality, particularly in those with structural heart disease, inherited cardiomyopathies, and channelopathies. The goals of ventricular arrhythmia management include symptom relief, improving quality of life, reducing implantable cardioverter defibrillator shocks, preventing deterioration of left ventricular function, reducing risk of arrhythmic death, and potentially improving overall survival. Guideline-directed medical therapy and implantable cardioverter defibrillator implantation remain the mainstay of therapy to prevent sudden cardiac death in patients with ventricular arrhythmias in the setting of structural heart disease. Recent advances in imaging modalities and commercial availability of genetic testing panels have enhanced our mechanistic understanding of the disease processes and, along with significant progress in catheter-based ablative therapies, have enabled a tailored and more effective management of drug-refractory ventricular arrhythmias. Several gaps in our knowledge remain and require further research. In this article, we review the recent advances in the diagnosis and management of ventricular arrhythmias."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/6-1027/v1",
            "name": "Recent advances in the management of ventricular tachyarrhythmias"
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Recent advances in the management of ventricular tachyarrhythmias </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=12086 data-id=11202 data-downloads="" data-views="" data-scholar="10.12688/f1000research.11202.1" data-recommended="" data-doi="10.12688/f1000research.11202.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/6-1027/v1/pdf?article_uuid=8bc7d05f-e5bf-4f1b-9ebe-05a6057ff9d7" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-11202-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-11202-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-11202-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Batul SA, Olshansky B, Fisher JD and Gopinathannair R. Recent advances in the management of ventricular tachyarrhythmias [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):1027 (<a class=new-orange href="https://doi.org/10.12688/f1000research.11202.1" target=_blank>https://doi.org/10.12688/f1000research.11202.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-11202-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=11202 id=track-article-signin-11202 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/11202?target=/articles/6-1027/v1">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=12086 /> <input name=articleId type=hidden value=11202 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Recent advances in the management of ventricular tachyarrhythmias</h1><span class=other-info> [version 1; peer review: 2 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class="">Syeda Atiqa Batul<sup>1</sup>,&nbsp;</span><span class="">Brian Olshansky<sup>2</sup>,&nbsp;</span><span class="">John D. Fisher<sup>1</sup>,&nbsp;</span><span class=""><a href="mailto:rakesh.gopinathannair@louisville.edu" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Rakesh Gopinathannair</span></a><a href="https://orcid.org/0000-0003-4611-3687" target=_blank id=author-orcid-3><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-3><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0003-4611-3687</div><sup>3</sup></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class="">Syeda Atiqa Batul<sup>1</sup>,&nbsp;</span><span class="">Brian Olshansky<sup>2</sup>,&nbsp;</span><span class="">John D. Fisher<sup>1</sup>,&nbsp;</span><span class=""><a href="mailto:rakesh.gopinathannair@louisville.edu" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Rakesh Gopinathannair</span></a><a href="http://orcid.org/0000-0003-4611-3687" target=_blank id=mauthor-orcid-3><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-3><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0003-4611-3687</div><sup>3</sup></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 29 Jun 2017 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.11202.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Arrhythmia Division, Montefiore Medical Center, Bronx, New York, USA<br/> <sup>2</sup> University of Iowa Hospitals and Clinics, Iowa City, USA<br/> <sup>3</sup> Division of Cardiovascular Medicine, University of Louisville School of Medicine, Louisville, USA<br/> <p> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=23850-23772></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=23851-23771></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> Ventricular arrhythmias are an important cause of cardiovascular morbidity and mortality, particularly in those with structural heart disease, inherited cardiomyopathies, and channelopathies. The goals of ventricular arrhythmia management include symptom relief, improving quality of life, reducing implantable cardioverter defibrillator shocks, preventing deterioration of left ventricular function, reducing risk of arrhythmic death, and potentially improving overall survival. Guideline-directed medical therapy and implantable cardioverter defibrillator implantation remain the mainstay of therapy to prevent sudden cardiac death in patients with ventricular arrhythmias in the setting of structural heart disease. Recent advances in imaging modalities and commercial availability of genetic testing panels have enhanced our mechanistic understanding of the disease processes and, along with significant progress in catheter-based ablative therapies, have enabled a tailored and more effective management of drug-refractory ventricular arrhythmias. Several gaps in our knowledge remain and require further research. In this article, we review the recent advances in the diagnosis and management of ventricular arrhythmias. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> Ventricular Arrhythmias, cardiomyopathy, catheter ablation, implantable cardioverter-defibrillator </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Rakesh Gopinathannair (<a href="mailto:rakesh.gopinathannair@louisville.edu">rakesh.gopinathannair@louisville.edu</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Rakesh Gopinathannair </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> SAB declares that she has no competing interests. BO has served as a consultant to Daiichi-Sankyo, Biotronik, Cardionomics, BioControl, Amarin, Boehringer Ingelheim, On-X, Abbott Vascular, and Sanofi. JDF has served as a consultant to Medtronic and has received fellowship support from Medtronic, Boston Scientific, Biotronik, and St. Jude Medical. RG has served as a consultant to St. Jude Medical and served on speakers&rsquo; bureaus of the American Heart Association, Pfizer, Bristol-Myers Squibb, Zoll Medical, and AltaThera Pharmaceuticals and on an advisory board of HealthTrust PG. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> The author(s) declared that no grants were involved in supporting this work. </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp; © 2017 Batul SA <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Batul SA, Olshansky B, Fisher JD and Gopinathannair R. Recent advances in the management of ventricular tachyarrhythmias [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):1027 (<a href="https://doi.org/10.12688/f1000research.11202.1" target=_blank>https://doi.org/10.12688/f1000research.11202.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 29 Jun 2017, <b>6</b>(F1000 Faculty Rev):1027 (<a href="https://doi.org/10.12688/f1000research.11202.1" target=_blank>https://doi.org/10.12688/f1000research.11202.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 29 Jun 2017, <b>6</b>(F1000 Faculty Rev):1027 (<a href="https://doi.org/10.12688/f1000research.11202.1" target=_blank>https://doi.org/10.12688/f1000research.11202.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d21594e204>Introduction</h2><p class="" id=d21594e207>Sudden cardiac death claims 350,000 to 400,000 lives annually in the US<sup><a href="#ref-1">1</a></sup>. Ventricular fibrillation (VF) or pulseless ventricular tachycardia (VT) accounts for 25 to 36% of witnessed cardiac arrests at home and 38 to 79% of witnessed cardiac arrests in public<sup><a href="#ref-2">2</a></sup>. Ventricular arrhythmias (VAs) represent a broad spectrum spanning single ectopic beats to sustained VT and VF. These arrhythmias encompass clinical conditions ranging from benign to life threatening. Sustained VAs are mostly associated with structural or ischemic heart disease (60 to 80%) followed by channelopathies and idiopathic VAs (VA in the absence of structural heart disease)<sup><a href="#ref-3">3</a>,<a href="#ref-4">4</a></sup>. Although life-threatening VAs are greatest in those with known coronary artery disease, myocardial infarction, and depressed ejection fraction, a considerable number of patients with non-ischemic cardiomyopathy (NICM) experience fatal events due to VT or VF as well<sup><a href="#ref-5">5</a></sup>.</p><p class="" id=d21594e229>Different forms of VAs can coexist in the same patient, can be isolated or frequent, and have differing mechanisms. Premature ventricular contractions are the most common and are generally considered benign. Non-sustained VT is at least three consecutive ventricular beats at a rate of at least 100 beats per minute; if VT exceeds 30 seconds or is hemodynamically unstable, it is considered “sustained”. VT can be regular or irregular in rate and morphology. Sustained monomorphic VT has the same activation sequence from beat to beat and generally occurs because of a stable re-entry circuit in patients with structural heart disease or because of automaticity in idiopathic VTs. The 12-lead electrocardiogram (ECG) provides an approximation of the exit site. On the other hand, polymorphic VT that often degenerates into VF is more often seen in acute myocardial ischemia or infarction as well as with several genetically mediated syndromes<sup><a href="#ref-6">6</a></sup>.</p><p class="" id=d21594e236>The goals of management of VAs include symptom relief (including syncope, worsening heart failure, and ischemic chest pain), improving quality of life, reducing implantable cardioverter defibrillator (ICD) shocks, preventing deterioration of left ventricular function, reducing risk of arrhythmic death, and improving overall survival<sup><a href="#ref-7">7</a>–<a href="#ref-10">10</a></sup>. Treatment of VAs should take into account the underlying medical conditions, the cardiac disorders, the presence of heart failure, the cause for the arrhythmias, consequences of the VAs, and the risks and benefits of the therapeutic pharmacological or invasive strategy<sup><a href="#ref-6">6</a>,<a href="#ref-8">8</a>,<a href="#ref-9">9</a></sup>.</p><p class="" id=d21594e256>ICDs are the mainstay of therapy to reduce the risk of sudden cardiac death due to VT and VF. Despite the mortality benefit gained from ICD therapy, electrical shocks from the device as well as unopposed and unnecessary right ventricular pacing should be monitored for and appropriately addressed<sup><a href="#ref-7">7</a>,<a href="#ref-11">11</a>–<a href="#ref-13">13</a></sup>. According to current data, both anti-arrhythmic drugs and catheter ablation may reduce the recurrence of VAs without offering any survival benefit<sup><a href="#ref-10">10</a></sup>. Recurrent ventricular tachyarrhythmias and ICD shocks are the major indication for anti-arrhythmic drug therapy, but these medications can also be pro-arrhythmic<sup><a href="#ref-13">13</a></sup>. Catheter ablation has evolved as a promising therapy to reduce the risk of VT recurrence; it is superior to medical therapy alone, according to clinical trials<sup><a href="#ref-14">14</a>–<a href="#ref-16">16</a></sup>. Despite improved mechanistic understanding and progress in catheter ablation technology that has led to effective treatment of focal and idiopathic VT, the long-term success rates for VT ablation remain modest in both ischemic and non-ischemic cardiomyopathies<sup><a href="#ref-17">17</a></sup>.</p><p class="" id=d21594e289>Considerable research and clinical effort in recent years have been focused on the development of diagnostic modalities and imaging tools to identify the arrhythmogenic substrate responsible for VT (focal or scar), genetic screening for markers of channelopathies, and superior mapping and ablation technologies. These advances have allowed us to tailor our approach to VA management on the basis of the underlying etiology with higher efficacy<sup><a href="#ref-6">6</a>,<a href="#ref-8">8</a>,<a href="#ref-9">9</a></sup>.</p><p class="" id=d21594e302>In this review, we aim to provide an update on the newer advances in the management of VAs.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d21594e308>Update on diagnostic and non-invasive imaging modalities</h2><p class="" id=d21594e311>For over 100 years, cardiologists relied on the ECG, monitoring strategies, and limited intracardiac electrodes to diagnose VAs. With mechanisms of VT now better defined in structural heart disease, non-invasive imaging modalities—including echocardiography, cardiac computed tomography (CT), cardiac magnetic resonance imaging (MRI) (CMR), and nuclear studies—have become an integral part of the diagnostic and management strategy. The information derived from these tests not only is important to identify those with structural heart disease, assess left and right ventricular function, and risk-stratify those at highest risk of inducible VT/VF on the basis of scar size in order to select the patients who would derive the most benefit from an ICD but also serves as a guide for planning ablation procedures<sup><a href="#ref-8">8</a>,<a href="#ref-18">18</a>,<a href="#ref-19">19</a></sup>. The 2015 European Society of Cardiology Guidelines have extended a class IIa recommendation to perform CMR or CT in patients where echocardiography fails to provide accurate assessment of ventricular function or underlying structural changes that may be arrhythmogenic, such as the scar size, distribution, and transmurality<sup><a href="#ref-8">8</a></sup>.</p><p class="" id=d21594e328>Although there are no large randomized controlled trials, multiple small studies have reported a potential benefit of obtaining pre-procedural imaging such as delayed enhancement CMR (DE-MRI) and incorporating the information into intracardiac mapping systems<sup><a href="#ref-20">20</a></sup>. Piers <i>et al</i>.<sup><a href="#ref-21">21</a></sup> described the characteristics of critical isthmus sites in 44 patients with ischemic cardiomyopathy and NICM undergoing VT ablation with pre-procedural CMR. The authors found the critical VT isthmus sites to be in close proximity to areas of higher (&gt;75%) scar transmurality and scar border zones as noted in CMR.</p><p class="" id=d21594e342>Contrast-enhanced MRI- and CT-derived scar data have been shown to correlate well with electroanatomic mapping (EAM) reconstructions. In a recent study by Esposito <i>et al</i>.<sup><a href="#ref-22">22</a></sup>, CT with delayed enhancement provided a detailed three-dimensional (3D) scar characterization with good sensitivity (76%) and specificity (86%) and a very high negative predictive value (95%) when correlated with voltage on EAM. Whereas EAM may be unable to quantify the non-transmural parts of the scar, information obtained from pre-procedural CMR may help in these instances.</p><p class="" id=d21594e352>Substrate characterization with CMR is also very useful in hypertrophic cardiomyopathy (HCM), arrhythmogenic right ventricular dysplasia (ARVD), and acquired immunological and inflammatory conditions (for example, sarcoidosis)<sup><a href="#ref-22">22</a>–<a href="#ref-28">28</a></sup>. A minority of patients with sustained left bundle branch block and inferior axis morphology VT, resembling idiopathic outflow tract VT, may have early concealed ARVD. CMR can help differentiate true idiopathic VT from early-stage ARVD or sarcoidosis and change the clinical approach for these patients<sup><a href="#ref-29">29</a></sup>. CMR may be of particular value in those with abnormal resting ECG (for example, right precordial T wave inversion in V1–V3).</p><p class="" id=d21594e367>Contrast CT has the added advantage of providing good visualization of coronary arteries. Lipomatous metaplasia (myocardial fat deposition) along with fibrosis in areas of chronic myocardial infarction has been observed in patients with ischemic heart disease on contrast CT and has been associated with fractionated electrograms and critical VT circuits<sup><a href="#ref-30">30</a></sup>. In patients with VT due to a local (myocarditis) or systemic (for example, sarcoidosis) inflammatory condition, fluorine-18 fluoro-2-deoxyglucose (18-FDG) positron emission tomography (PET/CT) can identify patients who may benefit from early immunosuppressive therapy versus catheter ablation<sup><a href="#ref-31">31</a></sup>.</p><p class="" id=d21594e378>The future of non-invasive mapping of VAs will focus on the creation of image-based simulation to estimate ablation targets in VAs, integration of multi-lead electrocardiography to construct computerized activation maps, and endo-epicardial and perhaps also mid-myocardial signal-intensity mapping that will identify the pathological substrates and VT exit sites which can be targeted more efficaciously<sup><a href="#ref-32">32</a>–<a href="#ref-34">34</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d21594e391>Advances in channelopathies and inherited cardiomyopathies</h2><p class="" id=d21594e394>Up to half of the families of sudden cardiac arrest victims below 50 years of age are carriers of cardiac genetic channelopathies or hereditary cardiomyopathies. The 2015 Expert Consensus Statement from the Heart Rhythm Society recommends that patients and first-degree relatives with diagnosed or suspected inherited cardiovascular disease as a potential cause of sudden cardiac arrest be evaluated in a dedicated clinic with appropriately trained staff (class I)<sup><a href="#ref-9">9</a>,<a href="#ref-35">35</a></sup>.</p><p class="" id=d21594e404>Extended molecular gene panels now can be performed at appropriate centers at a low cost, allowing early identification of a channelopathy or inherited cardiomyopathy. This, in turn, allows risk stratification of sudden cardiac death and introduction of appropriately timed therapy (lifestyle changes, pharmacologic therapy versus ICD implantation or catheter ablation or both (<a href="#T1">Table 1</a>)<sup><a href="#ref-9">9</a>,<a href="#ref-35">35</a>–<a href="#ref-37">37</a></sup>.</p><div class="table-wrap panel clearfix"><a name=T1 class=n-a></a><div class=caption><h3>Table 1. Heart Rhythm Society/European Society of Cardiology recommendations for the diagnosis and treatment of genetic arrhythmia syndrome and inherited cardiomyopathies.</h3></div><table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d21594e431 class=n-a></a><thead><a name=d21594e433 class=n-a></a><tr><a name=d21594e435 class=n-a></a><th align=left colspan=1 rowspan=1><a name=d21594e437 class=n-a></a>Genetic<br class=br>arrhythmia<br class=br>syndrome</th><th align=left colspan=1 rowspan=1><a name=d21594e444 class=n-a></a>Associated gene and ion channel<br class=br>affected</th><th align=left colspan=1 rowspan=1><a name=d21594e449 class=n-a></a>Recommendations for diagnosis</th><th align=left colspan=1 rowspan=1><a name=d21594e452 class=n-a></a>Recommendations for treatment</th></tr></thead><tbody><a name=d21594e457 class=n-a></a><tr><a name=d21594e459 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d21594e461 class=n-a></a>LQTS</td><td colspan=1 rowspan=1 valign=top><a name=d21594e464 class=n-a></a>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;Associated with mutations in at<br class=br>least 15 genes<br class=br>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;Three main genes: <i>KCNQ1</i><br class=br>(LQTS1), <i>KNCH2</i> (LQTS2), and<br class=br><i>SCN5A</i> (LQTS3) (75% of cases)<br class=br>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;<i>IKr</i> (LQTS1), <i>IKs</i> (LQTS2), <i>INa</i><br class=br>(LQTS3), <i>IK1</i> (LQTS7), and <i>ICa-L</i><br class=br>(LQTS8)<br class=br>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;AD LQTS with QT prolongation<br class=br>alone (Romano-Ward syndrome)<br class=br>LQTS 1–6<br class=br>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;AD LQTS7 (Anderson-Tawil<br class=br>syndrome): facial dysmorphism<br class=br>and hyper/hypokalemic periodic<br class=br>paralysis<br class=br>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;AD LQTS8 (Timothy<br class=br>syndrome) prolonged QT,<br class=br>facial dysmorphism, cardiac<br class=br>malformations, and autism<br class=br>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;Autosomal recessive LQTS<br class=br>(Jervell and Lange-Nielson<br class=br>syndrome) extremely prolonged<br class=br>QT interval with congenital<br class=br>deafness</td><td colspan=1 rowspan=1 valign=top><a name=d21594e538 class=n-a></a>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;QTc ≥ 480 ms in repeated 12-<br class=br>lead ECGs or LQTS risk score &gt;3<br class=br>(class I)<br class=br>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;Confirmed pathogenic LQTS<br class=br>mutations (class I)<br class=br>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;QTc ≥ 460 ms with unexplained<br class=br>syncopal episode in the absence of secondary<br class=br>causes of QT<br class=br>prolongation</td><td colspan=1 rowspan=1 valign=top><a name=d21594e558 class=n-a></a>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;Avoid QT prolonging agents, correct<br class=br>electrolytes, and avoid genotype-<br class=br>specific triggers (for example,<br class=br>strenuous exercise for LQTS1 and<br class=br>loud noise for LQTS2)<br class=br>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;BBs are recommended for patients<br class=br>with clinical diagnosis (class I) and<br class=br>carriers of causative mutation and<br class=br>normal QTc (class IIa)<br class=br>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;ICD should be implanted in patients<br class=br>with prior SCA (class I), syncope<br class=br>and/or VT while on adequately<br class=br>dosed BBs (class IIa) or considered<br class=br>in addition to BBs in asymptomatic<br class=br>carriers of <i>KCNH2</i> or <i>SCN5A</i><br class=br>mutations and a QTc &gt; 500 ms<br class=br>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;LCSD can be attempted in patients<br class=br>with ineffective or poorly tolerated<br class=br>BB therapy, contraindication to ICD,<br class=br>or incessant VT, multiple ICD shocks<br class=br>(class IIa)<br class=br>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;Sodium channel blockers<br class=br>(Mexiletine, Flecainide, Ranolazine)<br class=br>may be used as adjunctive therapy<br class=br>in LQTS3 with QTc &gt;500 ms<br class=br>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;Invasive EPS and PVS is not<br class=br>recommended for risk stratification (class III)</td></tr><tr><a name=d21594e623 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d21594e625 class=n-a></a>SQTS</td><td colspan=1 rowspan=1 valign=top><a name=d21594e628 class=n-a></a>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;<i>KCNH2</i> (SQT1), <i>KCNQ1</i> (SQT2),<br class=br>and <i>KCNJ2</i> (SQT3)<br class=br>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;<i>IKr</i> (SQT1), <i>IKs</i> (SQT2), and <i>IK1</i><br class=br>(SQT3)</td><td colspan=1 rowspan=1 valign=top><a name=d21594e655 class=n-a></a>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;QTc ≤ 340 ms on ECG (class I)<br class=br>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;QTc ≤ 360 ms and confirmed<br class=br>pathogenic mutation, family<br class=br>history of SQTS, family history<br class=br>of SCD &lt;40 years, survival from<br class=br>VT/VF in the absence of heart<br class=br>disease (class IIa)</td><td colspan=1 rowspan=1 valign=top><a name=d21594e671 class=n-a></a>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;ICD implant is recommended in<br class=br>patients with spontaneous sustained<br class=br>VT or SCA (class I)<br class=br>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;Quinidine or sotalol are<br class=br>recommended in patients who<br class=br>refuse or have a contraindication to<br class=br>ICD or in asymptomatic patients with<br class=br>SQTS and a family history of SCD<br class=br>(class IIb)<br class=br>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;Invasive EPS and PVS are not<br class=br>recommended for risk stratification<br class=br>(class III).</td></tr><tr><a name=d21594e698 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d21594e700 class=n-a></a>BrS</td><td colspan=1 rowspan=1 valign=top><a name=d21594e703 class=n-a></a>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;Inherited AD<br class=br>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;12 genetic mutations identified<br class=br>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;<i>SCN5A</i> and <i>CACN1Ac</i> (account for<br class=br>more than 5% of positively<br class=br>genotyped patients)<br class=br>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;Genetic screening does not affect<br class=br>treatment or prognosis.</td><td colspan=1 rowspan=1 valign=top><a name=d21594e725 class=n-a></a>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;ST-segment elevation with type<br class=br>1 morphology ≥2 mm elevation<br class=br>in one or more right precordial<br class=br>leads V1 and/or V2 positioned<br class=br>in the second, third, or fourth<br class=br>intercostal space, occurring either<br class=br>spontaneously or after provocative<br class=br>drug test with intravenous<br class=br>administration of sodium channel<br class=br>blockers such as ajmaline,<br class=br>flecainide, and procainamide<br class=br>(class I)</td><td colspan=1 rowspan=1 valign=top><a name=d21594e751 class=n-a></a>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;Lifestyle changes: Patients should<br class=br>avoid drugs that may induce<br class=br>ST elevation, excessive alcohol<br class=br>consumption, and seek prompt<br class=br>treatment of fever (class I)<br class=br>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;ICD implantation is recommended in<br class=br>survivors of SCA and/or spontaneous<br class=br>sustained VT or both (class I) or in<br class=br>patients with spontaneous Brugada<br class=br>pattern and history of syncope<br class=br>(class IIa) or patients with diagnosis<br class=br>of BrS who develop VF during PVS with<br class=br>two or three extra stimuli at two sites<br class=br>(class IIb)<br class=br>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;Quinidine or isoproterenol to be<br class=br>considered in electrical storm (class<br class=br>IIa). Quinidine should be considered<br class=br>in patients with BrS who refuse<br class=br>or have a contraindication to ICD<br class=br>implantation (class IIa)<br class=br>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;Catheter ablation may be considered<br class=br>in patients with repeated ICD shocks<br class=br>and electrical storm (class IIb).</td></tr><tr><a name=d21594e802 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d21594e804 class=n-a></a>ERS</td><td colspan=1 rowspan=1 valign=top><a name=d21594e807 class=n-a></a>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;Polygenic<br class=br>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;Role of genetic screening is not<br class=br>clear<br class=br>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;<i>IK-ATP</i> (ERS1, 5), <i>ICa</i> (ERS2-4),<br class=br>and <i>INa</i> (ERS6)<br class=br>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;No clear familial transmission</td><td colspan=1 rowspan=1 valign=top><a name=d21594e830 class=n-a></a>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;Asymptomatic early repolarization<br class=br>pattern is common in general<br class=br>population.<br class=br>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;ERS diagnosed only in patients<br class=br>with a pattern and documented<br class=br>idiopathic VF or polymorphic VT</td><td colspan=1 rowspan=1 valign=top><a name=d21594e843 class=n-a></a>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;Insufficient evidence to make<br class=br>definitive recommendations</td></tr><tr><a name=d21594e849 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d21594e851 class=n-a></a>CPVT</td><td colspan=1 rowspan=1 valign=top><a name=d21594e854 class=n-a></a>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;Dominant variant: ryanodine<br class=br>receptor gene (<i>RyR2</i>)<br class=br>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;Rare recessive variant: cardiac<br class=br>calsequestrin gene (<i>CASQ2</i>)<br class=br>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;Other genes: <i>KCNJ2, Ank2,</i><br class=br><i>TRDN</i>, and <i>CALM1</i> </td><td colspan=1 rowspan=1 valign=top><a name=d21594e881 class=n-a></a>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;Induction of bidirectional or<br class=br>polymorphic VT in the presence of<br class=br>structurally normal heart and ECG<br class=br>(class I)<br class=br>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;Diagnosed carriers of a<br class=br>pathogenic mutation on genetic<br class=br>screening (<i>RyR2</i> or <i>CASQ2</i>)</td><td colspan=1 rowspan=1 valign=top><a name=d21594e903 class=n-a></a>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;Avoidance of competitive sports,<br class=br>stress environments, and strenuous<br class=br>exercise (class I)<br class=br>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;BBs recommended for all patients<br class=br>(class I), genetically positive family<br class=br>members of proband without<br class=br>exercise induced VT (class IIa)<br class=br>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;Flecainide should be considered<br class=br>in addition to BBs in patients with<br class=br>recurrent syncope or VT or with<br class=br>contraindication to ICD (class IIa)<br class=br>or in patients with ICD to reduce<br class=br>shocks (class IIa)<br class=br>•&nbsp;&nbsp;&nbsp;ICD and BBs and/or flecainide<br class=br>in patients with SCA, recurrent<br class=br>syncope, or polymorphic VT despite<br class=br>optimal therapy (class I)<br class=br>•&nbsp;&nbsp;&nbsp;LCSD can be performed in CPVT<br class=br>patients with recurrent syncope,<br class=br>arrhythmia, recurrent ICD shocks<br class=br>while on maximal therapy or who are<br class=br>intolerant to medical therapy (class IIb)<br class=br>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;Invasive EPS with PVS is not<br class=br>recommended for risk stratification<br class=br>(class III).</td></tr><tr><a name=d21594e960 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d21594e962 class=n-a></a>HCM</td><td colspan=1 rowspan=1 valign=top><a name=d21594e965 class=n-a></a>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;AD<br class=br>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;10 genes encoding from proteins<br class=br>in cardiac sarcomere<br class=br>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;Beta-myosin, troponin T and I,<br class=br>alpha-tropomyosin, myosin light<br class=br>chains, titin, alpha actin, alpha<br class=br>myosin heavy chain, and muscle<br class=br>LIM protein (MLP)<br class=br>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;Non-sarcomeric protein mutations<br class=br>(storage disease) clinically similar<br class=br><i>PRKAG2, LAMP2</i> <br class=br>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;Commercially available genetic<br class=br>testing</td><td colspan=1 rowspan=1 valign=top><a name=d21594e996 class=n-a></a>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;Left ventricular hypertrophy<br class=br>max wall thickness ≥15 mm,<br class=br>asymmetric (&gt;1.3:1), concomitant<br class=br>obstructive pathology and<br class=br>mitral regurgitation, diastolic<br class=br>dysfunction, abnormal papillary<br class=br>muscles on transthoracic<br class=br>echocardiography or cardiac<br class=br>magnetic resonance imaging<br class=br>(class I)<br class=br>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;Genetic testing is recommended<br class=br>in index patient and family<br class=br>members (class I)</td><td colspan=1 rowspan=1 valign=top><a name=d21594e1025 class=n-a></a>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;Avoidance of competitive sports,<br class=br>stress environments, and strenuous<br class=br>exercise (class I)<br class=br>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;ICD in survivors of SCA or sustained<br class=br>VT/VF causing syncope (class I)<br class=br>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;Risk stratification with HCM SCD<br class=br>risk calculator (class I)<br class=br>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;BBs or calcium channel blockers<br class=br>(class I) or disopyramide (class IIa)<br class=br>to treat obstructive symptoms.<br class=br>Guideline-directed medical therapy<br class=br>for congestive heart failure (class IIa)<br class=br>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;Invasive EPS with PVS is not<br class=br>recommended for risk stratification<br class=br>of SCD (class III)</td></tr></tbody></table><div class=table-wrap-foot><div class=footnote><a name=d21594e1063 class=n-a></a><p id=d21594e1065> AD, autosomal dominant; BB, beta blocker; BrS, Brugada syndrome; CPVT, catecholaminergic polymorphic ventricular tachycardia; ECG, electrocardiogram; EPS, electrophysiologic study; ERS, early repolarization syndrome; HCM, hypertrophic cardiomyopathy; ICD, implantable cardioverter defibrillator; LQTS, long QT syndrome; LCSD left cervical sympathetic denervation; PVS, programmed ventricular stimulation; SCA, sudden cardiac arrest; SCD, sudden cardiac death; SQTS, short QT syndrome; VF, ventricular fibrillation; VT, ventricular tachycardia.</p></div></div></div><p class="" id=d21594e1071>An important breakthrough in treating genetic arrhythmia syndromes has been the identification of a potential arrhythmic substrate located in the epicardial right ventricular outflow tract (RVOT) that may trigger VT/VF in some patients with Brugada syndrome. Epicardial 3D EAM has shown abnormal low voltage and fractionated late potentials clustered exclusively in the anterior RVOT epicardium. Ablation at these sites rendered VT/VF non-inducible in 78% and normalization of the Brugada ECG pattern (coved ST-elevations in V1 and V2) in 89%. A multicenter randomized study—Ablation in Brugada Syndrome for the Prevention of VF episodes (BRAVE Study)—is being planned and will assess long-term outcomes of catheter ablation in patients with Brugada syndrome<sup><a href="#ref-38">38</a>,<a href="#ref-39">39</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d21594e1084>Medical management of ventricular tachycardia in structural heart disease: Will there be a realm beyond amiodarone therapy?</h2><p class="" id=d21594e1087>Pharmacologic therapy for preventing VAs has yielded disappointing results in recent years. Therapy has been limited because of variable efficacy, pro-arrhythmic effects, patient compliance, and adverse effects from long-term therapy. As adjuvant suppressive therapy in patients with ICDs, amiodarone and sotalol have been shown to reduce the rate of recurrent VT (71% and 15–44%, respectively) when compared with beta-blockers or placebo<sup><a href="#ref-40">40</a></sup>. Current guidelines recommend pharmacologic therapy (amiodarone or sotalol) with or without adjunctive catheter ablation to prevent VT/VF recurrence and reducing ICD shocks<sup><a href="#ref-8">8</a>,<a href="#ref-16">16</a></sup>.</p><p class="" id=d21594e1101>Intravenous amiodarone and sodium channel blockers (lidocaine and procainamide) remain the preferred drug regimen in the acute setting; however, more recently, intravenous sotalol has been shown to terminate sustained VT acutely with a higher efficacy versus lidocaine<sup><a href="#ref-41">41</a></sup>. Neither amiodarone nor lidocaine, however, has been shown to improve survival or neurologic outcomes in patients with pulseless VT/VF and out-of-hospital cardiac arrest<sup><a href="#ref-42">42</a></sup>. In the first prospective randomized study comparing intravenous procainamide and amiodarone in the acute treatment of hemodynamically tolerated wide complex tachycardia (VAs), procainamide was shown to be more efficacious in tachycardia termination (67% versus 38%) and was associated with fewer major cardiovascular events (9% versus 41%). The effect was consistently observed even in those with structural heart disease as well as when adjusted for age and sex. Although this study had a limited number of patients and was not blinded, it still points to the efficacy and safety of intravenous procainamide in the acute treatment of VT<sup><a href="#ref-43">43</a></sup>.</p><p class="" id=d21594e1116>Investigators of the VANISH trial showed an improved composite primary outcome of death, VT storm, or appropriate ICD shocks among patients undergoing catheter ablation versus escalation of anti-arrhythmic drug therapy (amiodarone or mexiletine or both) but with no significant difference between groups in terms of mortality<sup><a href="#ref-44">44</a></sup>. In a recent meta-analysis comparing the effectiveness of anti-arrhythmic drugs versus catheter ablation for preventing recurrent VT in patients with ICDs, there was no significant difference between the two treatment modalities (odds ratio (OR) 0.58, 95% confidence interval (CI) 0.26–1.2, <i>P</i> = 0.17) in terms of risk reduction of VT as well as all-cause mortality (OR 0.58, 95% CI 0.24–1.24, <i>P</i> = 0.23)<sup><a href="#ref-10">10</a></sup>. To avoid potential long-term adverse effects and reduce mortality, amiodarone may be safely reduced or discontinued after successful VT ablation without an increase in VT recurrence<sup><a href="#ref-45">45</a></sup>.</p><p class="" id=d21594e1137>Nifekalant, a pure potassium channel blocker that has been approved for use in Japan for VT since 1999, has not been shown to be superior to amiodarone in treating out-of-hospital cardiac arrest or shock-resistant sustained VT/VF<sup><a href="#ref-46">46</a>,<a href="#ref-47">47</a></sup>. Azimilide, another class III agent (not approved in the US), has been shown to reduce VAs and appropriate ICD shocks in patients with cardiomyopathies, according to data from the SHIELD trial<sup><a href="#ref-48">48</a></sup>.</p><p class="" id=d21594e1152>Development of efficacious anti-arrhythmic drugs for VAs with a limited adverse-effect profile continues to be a challenge.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d21594e1158>What lies in the future for implantable device therapy</h2><p class="" id=d21594e1161>Next to guideline-directed medical therapy, ICDs can reduce the risk of sudden cardiac death according to several randomized controlled trials for secondary prevention in both ischemic cardiomyopathy and NICM<sup><a href="#ref-11">11</a></sup>. For primary prevention of sudden cardiac death, particularly in NICM, the benefit from ICD has been modest primarily because of a lower rate of spontaneous VT/VF. The DANISH investigators<sup><a href="#ref-49">49</a></sup> showed no significant overall mortality benefit from primary prevention ICD implantation in patients with NICM and symptomatic heart failure. Importantly, this observation seems to be age-dependent as patients younger than 59 years derive significant benefit from the ICD.</p><p class="" id=d21594e1172>Intravascular lead-related complications and inappropriate shocks are of particular significance in young patients with channelopathies and syndromes who are also at high risk for fatal VAs. ICD arrhythmia detection and programming algorithms have been refined over time to include higher minimum cutoff rates, extended detection time for VT, anti-tachycardia pacing, and morphology discriminators to minimize the risk of inappropriate shocks<sup><a href="#ref-11">11</a>,<a href="#ref-50">50</a></sup>.</p><p class="" id=d21594e1182>The development of an entirely subcutaneous ICD (S-ICD) system with efficacy similar to that of conventional ICD in terminating VT/VF has been a major advance in device technology<sup><a href="#ref-51">51</a>,<a href="#ref-52">52</a></sup>. Although randomized comparative data are not yet available, pooled data from the EFFORTLESS and IDE trials have shown the S-ICD to be a safe and effective alternative to conventional transvenous ICDs—especially in younger patients with HCM, genetic channelopathies, and adult complex congenital heart disease—as long as there is no need for pacing<sup><a href="#ref-52">52</a>–<a href="#ref-55">55</a></sup>. The rate of inappropriate shocks due to oversensing has been mitigated with the introduction of dual zone programming and algorithms to accommodate R- and T-wave amplitude variations<sup><a href="#ref-56">56</a></sup>.</p><p class="" id=d21594e1203>Two additional trials—PRAETORIAN and UNTOUCHED—will provide definitive data regarding a direct comparison of the S-ICD with a transvenous ICD system in terms of efficacy, appropriate and inappropriate shocks, and ICD-related complications<sup><a href="#ref-57">57</a>,<a href="#ref-58">58</a></sup>. An investigational percutaneous implantable intravascular defibrillator has also been developed that, compared with conventional ICD, has potentially lower complications and similar defibrillation thresholds<sup><a href="#ref-59">59</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d21594e1221>Invasive mapping and catheter ablation of ventricular tachycardia: Have we built the right tools to decode the substrate?</h2><p class="" id=d21594e1224>Catheter ablation guided by 3D EAM has emerged as an effective therapeutic option in patients with recurrent and sustained monomorphic VT, arrhythmia-induced cardiomyopathy, recurrent ICD shocks, intolerance to anti-arrhythmic medications, or a combination of these<sup><a href="#ref-16">16</a></sup>. Catheter ablation of VT has a reported complication rate ranging from 5 to 7% according to different studies and has low periprocedural mortality and VT termination in up to 70% of cases<sup><a href="#ref-16">16</a>,<a href="#ref-60">60</a>,<a href="#ref-61">61</a></sup>. The recurrence rate, however, remains high; 26 to 50% of patients experience recurrent VT during long-term follow-up<sup><a href="#ref-17">17</a>,<a href="#ref-62">62</a></sup>.</p><p class="" id=d21594e1248>The success rate of catheter ablation for scar-mediated VT is higher in ischemic cardiomyopathy<sup><a href="#ref-63">63</a></sup>. Substrate-guided VT ablation remains the preferred approach particularly when the arrhythmia is poorly tolerated. The VISTA trial showed an extensive substrate-based approach to be superior when compared with targeting clinical VT (15.5% VT recurrence in substrate-guided versus 48.3% in the clinical VT target group) in patients with ischemic cardiomyopathy<sup><a href="#ref-64">64</a></sup>. The limitation in achieving higher success in NICM may be related to the more heterogeneous distribution of disease as well as transmurality and epicardial extension of scar<sup><a href="#ref-62">62</a></sup>.</p><p class="" id=d21594e1263>Kumar <i>et al</i>.<sup><a href="#ref-65">65</a></sup> reported better survival and low VT recurrence in patients without structural heart disease undergoing catheter ablation of VT compared with those with ischemic and non-ischemic cardiomyopathy. During long-term follow-up, the highest VA recurrence was seen in NICM (about 75% of those with NICM had at least one VA recurrence) but patients with ischemic cardiomyopathy had higher overall mortality.</p><p class="" id=d21594e1273>Although we have limited data from randomized controlled trials and no proven mortality benefit yet for VT ablation in structural heart disease, recent studies do suggest that ablation results in improved quality of life, freedom from ICD shocks, and improved transplant-free survival. Tung <i>et al</i>.<sup><a href="#ref-66">66</a></sup> reported 1-year freedom from VT recurrence in up to 70% of patients with structural heart disease who underwent VT ablation (including 72% of patients with ischemic cardiomyopathy and 68% with NICM). Lack of recurrent VT translated as an improved transplant-free survival in this study<sup><a href="#ref-66">66</a></sup>. Data from the THERMOCOOL VT trial looking at the long-term success of open irrigated radiofrequency (RF) catheter ablation of monomorphic VT associated with coronary artery disease showed reduced ICD shocks and VT episodes with improved quality of life at 6 months. At 3-year follow-up, non-recurrence resulted in decreased amiodarone use and hospitalizations<sup><a href="#ref-67">67</a></sup>.</p><p class="" id=d21594e1292>Other investigational and clinically tested techniques that could potentially improve substrate characterization, procedural outcomes and minimize complications include use of irrigated and contact force ablation catheters, incorporation of pre-procedural and intra-procedural imaging, ablation of deep myocardial substrate with bipolar RF ablation, transcoronary alcohol injection, coronary coil embolization, epicardial ablation, surgical cryoablation, and remote magnetic navigation, and stereotactic ablative radiotherapy (<a href="#T2">Table 2</a>)<sup><a href="#ref-68">68</a>–<a href="#ref-78">78</a></sup>. However, concrete data on the efficacy of these techniques is lacking and further studies are needed.</p><div class="table-wrap panel clearfix"><a name=T2 class=n-a></a><div class=caption><h3>Table 2. Investigational modalities for ventricular tachycardia ablation and suggested clinical applications.</h3></div><table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d21594e1316 class=n-a></a><thead><a name=d21594e1318 class=n-a></a><tr><a name=d21594e1320 class=n-a></a><th align=left colspan=1 rowspan=1><a name=d21594e1322 class=n-a></a>Innovative modality</th><th align=left colspan=1 rowspan=1><a name=d21594e1325 class=n-a></a>Investigators and initial reports</th><th align=left colspan=1 rowspan=1><a name=d21594e1328 class=n-a></a>Salient features and possible benefits</th></tr></thead><tbody><a name=d21594e1333 class=n-a></a><tr><a name=d21594e1335 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d21594e1337 class=n-a></a>MRI-guided stereotactic ablative radiotherapy<br class=br>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;For patients with VT who have failed<br class=br>standard therapy<br class=br>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;Uses anatomic scar imaging: MRI or<br class=br>SPECT or both with superimposed voltage<br class=br>map to accurately delineate scar</td><td colspan=1 rowspan=1 valign=top><a name=d21594e1350 class=n-a></a>Cuculich <i>et al</i>. - ENCORE-VT<br class=br>phase I/II study<sup><a href="#ref-83">83</a></sup><br class=br>Clinical trial: NCT02919618<br class=br>Loo <i>et al</i>. Stereotactic Ablative<br class=br>Radiotherapy (STAR)<sup><a href="#ref-84">84</a></sup><br class=br>Maguire <i>et al</i>. - CyberHeart’s<br class=br>Cardiac Arrhythmia Ablation<sup><a href="#ref-85">85</a></sup><br class=br>Clinical trial: NCT02661048 </td><td colspan=1 rowspan=1 valign=top><a name=d21594e1386 class=n-a></a>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;A rapid and totally non-invasive<br class=br>technique<br class=br>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;Pre-clinical data suggest significant<br class=br>reduction in VT burden (&gt;50%) and<br class=br>reduction in implantable cardioverter<br class=br>defibrillator therapy (&gt;85%).<br class=br>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;Clinical trials to determine the acute and<br class=br>long-term safety and efficacy initiated<br class=br>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;Gap-free ablation can be performed<br class=br>in short duration for medically frail<br class=br>population</td></tr><tr><a name=d21594e1411 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d21594e1413 class=n-a></a>Infusion needle catheter ablation<br class=br>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;Infusion needle catheter ablation is being<br class=br>studied for effectiveness in patients<br class=br>who have failed standard RF ablation,<br class=br>especially with deep mid-myocardial<br class=br>substrate for VT<br class=br>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;Needle design allows for myocardial<br class=br>penetration, infusion of heated saline and<br class=br>RF energy delivery<br class=br>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;Pre- and peri-procedural imaging helps<br class=br>guide the procedure (e.g; intracardiac<br class=br>echocardiography)</td><td colspan=1 rowspan=1 valign=top><a name=d21594e1439 class=n-a></a>Sapp <i>et al</i>.<sup><a href="#ref-77">77</a></sup><br class=br>Stevenson <i>et al</i>. Intramural Needle<br class=br>Ablation for Recurrent Ventricle<br class=br>Tachycardia<sup><a href="#ref-86">86</a></sup><br class=br>Clinical trial: NCT01791543</td><td colspan=1 rowspan=1 valign=top><a name=d21594e1463 class=n-a></a>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;A bipolar or quadripolar catheter<br class=br>equipped with an extensible needle that<br class=br>can project up to 12 mm beyond tip is<br class=br>used<br class=br>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;Heated saline can be infused through tip<br class=br>and side pores<br class=br>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;Flow rate of saline determines lesion size<br class=br>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;Large lesions can be created, does not<br class=br>require scar/lesion maturity</td></tr><tr><a name=d21594e1484 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d21594e1486 class=n-a></a>Facilitated RF ablation using magnetically<br class=br>directed nanoparticles<br class=br>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;Iron, carbon, or titanium nanoparticles are<br class=br>delivered within heat-sensitive liposomes<br class=br>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;Iron nanoparticles used in imaging<br class=br>considered safe<br class=br>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;Study <i>in vivo</i> porcine models</td><td colspan=1 rowspan=1 valign=top><a name=d21594e1505 class=n-a></a>Nguyen <i>et al</i>.<sup><a href="#ref-87">87</a></sup></td><td colspan=1 rowspan=1 valign=top><a name=d21594e1514 class=n-a></a>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;Nanoparticles have been shown to alter<br class=br>tissue sensitivity to RF energy with a<br class=br>potential to create deeper lesions<br class=br>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;Better tissue heating avoids “steam<br class=br>pops”</td></tr><tr><a name=d21594e1526 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d21594e1528 class=n-a></a>MRI-based signal intensity mapping for epicardial<br class=br>substrate<br class=br>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;The technique helps to identify epicardial<br class=br>substrate for monomorphic VT with<br class=br>contrast enhanced MRI<br class=br>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;Images can be correlated with standard<br class=br>electroanatomical mapping<br class=br>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;Clinical data based on <i>in vivo</i> porcine<br class=br>models available</td><td colspan=1 rowspan=1 valign=top><a name=d21594e1551 class=n-a></a>Arenal <i>et al</i>.<sup><a href="#ref-33">33</a></sup></td><td colspan=1 rowspan=1 valign=top><a name=d21594e1560 class=n-a></a>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;Epicardial VT substrate can be identified<br class=br>by contrast-enhanced MRI-based signal<br class=br>intensity mapping<br class=br>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;Patchy scar pattern may be associated<br class=br>with VT inducibility<br class=br>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;Potential non-invasive imaging modality<br class=br>to determine risk of inducible epicardial<br class=br>VT prior to planned procedure</td></tr><tr><a name=d21594e1579 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d21594e1581 class=n-a></a>MIBG imaging to guide VT ablation<br class=br>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;MIBG has characteristics similar to<br class=br>those of norepinephrine; it is taken up at<br class=br>presynaptic neurons<br class=br>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;3D models with MIBG are created to<br class=br>guide VT ablation<br class=br>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;A 15-patient feasibility study<br class=br>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;ADMIRE trial identified areas of cardiac<br class=br>denervation and correlations with death,<br class=br>heart failure, and VT/ventricular fibrillation<br class=br>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;MIBG (scan) US Food and Drug<br class=br>Administration-approved 2013</td><td colspan=1 rowspan=1 valign=top><a name=d21594e1607 class=n-a></a>Klein <i>et al</i>. - 3D MIBG Innervation<br class=br>Maps to assess substrate and<br class=br>successful ablation sites for VT<sup><a href="#ref-88">88</a></sup><br class=br>Jacobson <i>et al</i>. ADMIRE-HF<sup><a href="#ref-89">89</a></sup></td><td colspan=1 rowspan=1 valign=top><a name=d21594e1629 class=n-a></a>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;MIBG innervation defects are larger than<br class=br>scars created with bipolar voltage maps.<br class=br>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;In the pilot study 36% successful<br class=br>ablative sites were located in areas<br class=br>of abnormal innervation and normal<br class=br>voltage<br class=br>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;Voltage maps do not necessarily<br class=br>correlate with innervation maps.<br class=br>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;Innervation maps may help target<br class=br>additional sites of VT ablation not<br class=br>identified by EAM</td></tr><tr><a name=d21594e1655 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d21594e1657 class=n-a></a>Non-invasive high-resolution mapping and ECGI<br class=br>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;This technique offers single-beat<br class=br>panoramic mapping<br class=br>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;Both endocardial and epicardial mapping<br class=br>can be performed</td><td colspan=1 rowspan=1 valign=top><a name=d21594e1668 class=n-a></a>Reports from 1998 to 2015; Rudy<br class=br><i>et al</i>.<sup><a href="#ref-90">90</a>,<a href="#ref-91">91</a></sup><br class=br>Zhang <i>et al</i>.<sup><a href="#ref-92">92</a></sup></td><td colspan=1 rowspan=1 valign=top><a name=d21594e1689 class=n-a></a>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;Non-invasive modality to provide<br class=br>endocardial and epicardial substrate<br class=br>information<br class=br>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;Information can be used to risk-stratify<br class=br>patients and identify those at highest risk<br class=br>of ventricular arrhythmia.<br class=br>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;ECGI has been shown to have a high<br class=br>correlation with MRI and SPECT derived<br class=br>scar<br class=br>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;Anti-arrhythmic drug exposure could<br class=br>potentially affect amplitude and<br class=br>fractionation.</td></tr><tr><a name=d21594e1716 class=n-a></a><td colspan=1 rowspan=1 valign=top><a name=d21594e1718 class=n-a></a>Cardiac ripple mapping for slow conducting<br class=br>channels<br class=br>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;A novel method to incorporate voltage and<br class=br>activation data for EAM mapping<br class=br>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;High-density bipolar electrograms<br class=br>collected</td><td colspan=1 rowspan=1 valign=top><a name=d21594e1731 class=n-a></a>Luther <i>et al</i>.<sup><a href="#ref-93">93</a></sup><br class=br>Jamil-Copley <i>et al</i>.<sup><a href="#ref-94">94</a></sup></td><td colspan=1 rowspan=1 valign=top><a name=d21594e1748 class=n-a></a>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;Allows for simultaneous visualization of<br class=br>voltage and activation data incorporated<br class=br>on 3D EAM<br class=br>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;Enables identification of slow<br class=br>conduction channels within scar zones<br class=br>in myocardium that may be potential<br class=br>targets of VT ablation<br class=br>&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;Target-specific approach can improve<br class=br>efficacy of ablation.</td></tr></tbody></table><div class=table-wrap-foot><div class=footnote><a name=d21594e1773 class=n-a></a><p id=d21594e1775> 3D, three-dimensional; EAM, electroanatomic map; ECGI, electrocardiographic imaging; MIBG, <sup>123</sup>I-meta-iodobenzylguanidine; MRI, magnetic resonance imaging; RF, radiofrequency; SPECT, single-photon emission computed tomography; VT, ventricular tachycardia.</p></div></div></div><p class="" id=d21594e1784>However, concrete data for their efficacy are lacking and more studies are needed. Epicardial substrate ablation has been identified as a potentially successful ablation strategy to eliminate VAs in select patients with ARVD and NICM and more recently in patients with Brugada syndrome<sup><a href="#ref-38">38</a>,<a href="#ref-39">39</a>,<a href="#ref-79">79</a></sup>. In patients with incessant VT who have failed conventional and ablative therapy, left or bilateral cervical sympathectomy has been shown in observational studies to reduce VT recurrence, but larger studies are needed to establish the safety and efficacy of this procedure<sup><a href="#ref-80">80</a>–<a href="#ref-82">82</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d21594e1807>Conclusions</h2><p class="" id=d21594e1810>VAs encompass a broad range of clinical conditions ranging from benign to life-threatening. Sustained VAs are a major cause of morbidity and mortality in patients with structural heart disease. In addition to refinement and evolution of well-established therapies such as anti-arrhythmic drugs and ICDs, several major advances in the mechanistic, genetic, diagnostic, and therapeutic realms have furthered our understanding of the pathophysiology of ventricular tachyarrhythmias and helped fashion safer and more effective therapies particularly for drug-refractory VAs. Several gaps in our knowledge remain and require further research. Ultimately, successful short- and long-term management of VAs will likely integrate biological, pharmacologic, device-based, and ablative therapies.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d21594e1816>Abbreviations</h2><p class="" id=d21594e1819>3D, three-dimensional; ARVD, arrhythmogenic right ventricular dysplasia; CI, confidence interval; CMR, cardiac magnetic resonance imaging; CT, computed tomography; EAM, electroanatomic mapping; ECG, electrocardiogram; HCM, hypertrophic cardiomyopathy; ICD, implantable cardioverter defibrillator; MRI, magnetic resonance imaging; NICM, non-ischemic cardiomyopathy; OR, odds ratio; RF, radiofrequency; RVOT, right ventricular outflow tract; S-ICD, subcutaneous ICD; VA, ventricular arrhythmia; VF, ventricular fibrillation; VT, ventricular tachycardia.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d21594e1 class=n-a></a><h2 class=main-title id=d21895>Author contributions</h2><p class=metadata-entry><a name=d21594e133 class=n-a></a><p id=d21594e135> SAB, BO, and JDF contributed to drafting and making critical revisions of the manuscript. RG contributed to supervision and to drafting and making critical revisions of the manuscript for key intellectual content.</p></p></div><div class=back-section><a name=d21594e1 class=n-a></a><h2 class=main-title id=d21899>Competing interests</h2><p class=metadata-entry><a name=d21594e139 class=n-a></a><p id=d21594e141> SAB declares that she has no competing interests. BO has served as a consultant to Daiichi-Sankyo, Biotronik, Cardionomics, BioControl, Amarin, Boehringer Ingelheim, On-X, Abbott Vascular, and Sanofi. JDF has served as a consultant to Medtronic and has received fellowship support from Medtronic, Boston Scientific, Biotronik, and St. Jude Medical. RG has served as a consultant to St. Jude Medical and served on speakers’ bureaus of the American Heart Association, Pfizer, Bristol-Myers Squibb, Zoll Medical, and AltaThera Pharmaceuticals and on an advisory board of HealthTrust PG.</p></p></div><div class=back-section><a name=d21594e1 class=n-a></a><h2 class=main-title id=d21901>Grant information</h2><p>The author(s) declared that no grants were involved in supporting this work.</p></div><div class=back-section><a name=d21594e1826 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d22198>References</h2><div class="section ref-list"><a name=d21594e1826 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d21594e1833 class=n-a></a>Go AS, Mozaffarian D, Roger VL, <i> et al.</i>: Heart disease and stroke statistics--2014 update: a report from the American Heart Association. <i>Circulation.</i> 2014; <b>129</b>(3): e28–e292. <a target=xrefwindow id=d21594e1844 href="http://www.ncbi.nlm.nih.gov/pubmed/24352519">PubMed Abstract </a> | <a target=xrefwindow id=d21594e1847 href="http://dx.doi.org/10.1161/01.cir.0000441139.02102.80">Publisher Full Text </a> | <a target=xrefwindow id=d21594e1851 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5408159">Free Full Text </a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d21594e1860 class=n-a></a>Weisfeldt ML, Everson-Stewart S, Sitlani C, <i> et al.</i>: Ventricular tachyarrhythmias after cardiac arrest in public versus at home. <i>N Engl J Med.</i> 2011; <b>364</b>(4): 313–21. <a target=xrefwindow id=d21594e1871 href="http://www.ncbi.nlm.nih.gov/pubmed/21268723">PubMed Abstract </a> | <a target=xrefwindow id=d21594e1874 href="http://dx.doi.org/10.1056/NEJMoa1010663">Publisher Full Text </a> | <a target=xrefwindow id=d21594e1878 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3062845">Free Full Text </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d21594e1887 class=n-a></a>Lo R, Chia KK, Hsia HH: Ventricular Tachycardia in Ischemic Heart Disease. <i>Card Electrophysiol Clin.</i> 2017; <b>9</b>(1): 25–46. <a target=xrefwindow id=d21594e1895 href="http://www.ncbi.nlm.nih.gov/pubmed/28167084">PubMed Abstract </a> | <a target=xrefwindow id=d21594e1898 href="http://dx.doi.org/10.1016/j.ccep.2016.10.013">Publisher Full Text </a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a name=d21594e1907 class=n-a></a>Benito B, Guasch E, Rivard L, <i> et al.</i>: Clinical and mechanistic issues in early repolarization of normal variants and lethal arrhythmia syndromes. <i>J Am Coll Cardiol.</i> 2010; <b>56</b>(15): 1177–86. <a target=xrefwindow id=d21594e1918 href="http://www.ncbi.nlm.nih.gov/pubmed/20883924">PubMed Abstract </a> | <a target=xrefwindow id=d21594e1921 href="http://dx.doi.org/10.1016/j.jacc.2010.05.037">Publisher Full Text </a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a name=d21594e1930 class=n-a></a>Chia KK, Hsia HH: Ventricular Tachycardia in Nonischemic Dilated Cardiomyopathy. <i>Card Electrophysiol Clin.</i> 2014; <b>6</b>(3): 535–52. <a target=xrefwindow id=d21594e1938 href="http://dx.doi.org/10.1016/j.ccep.2014.05.009">Publisher Full Text </a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a name=d21594e1948 class=n-a></a>Stevenson WG: Current treatment of ventricular arrhythmias: state of the art. <i>Heart Rhythm.</i> 2013; <b>10</b>(12): 1919–26. <a target=xrefwindow id=d21594e1956 href="http://www.ncbi.nlm.nih.gov/pubmed/24120875">PubMed Abstract </a> | <a target=xrefwindow id=d21594e1959 href="http://dx.doi.org/10.1016/j.hrthm.2013.10.019">Publisher Full Text </a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a name=d21594e1968 class=n-a></a>Hohnloser SH, Israel CW: Current evidence base for use of the implantable cardioverter-defibrillator. <i>Circulation.</i> 2013; <b>128</b>(2): 172–83. <a target=xrefwindow id=d21594e1976 href="http://www.ncbi.nlm.nih.gov/pubmed/23836830">PubMed Abstract </a> | <a target=xrefwindow id=d21594e1979 href="http://dx.doi.org/10.1161/CIRCULATIONAHA.112.000547">Publisher Full Text </a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d21594e1988 class=n-a></a>Priori SG, Blomström-Lundqvist C, Mazzanti A, <i> et al.</i>: 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). <i>Eur Heart J.</i> 2015; <b>36</b>(41): 2793–867. <a target=xrefwindow id=d21594e1999 href="http://www.ncbi.nlm.nih.gov/pubmed/26320108">PubMed Abstract </a> | <a target=xrefwindow id=d21594e2002 href="http://dx.doi.org/10.1093/eurheartj/ehv316">Publisher Full Text </a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d21594e2011 class=n-a></a>Priori SG, Wilde AA, Horie M, <i> et al.</i>: HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013. <i>Heart Rhythm.</i> 2013; <b>10</b>(12): 1932–63. <a target=xrefwindow id=d21594e2022 href="http://www.ncbi.nlm.nih.gov/pubmed/24011539">PubMed Abstract </a> | <a target=xrefwindow id=d21594e2025 href="http://dx.doi.org/10.1016/j.hrthm.2013.05.014">Publisher Full Text </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726210190"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21594e2034 class=n-a></a>Santangeli P, Muser D, Maeda S, <i> et al.</i>: Comparative effectiveness of antiarrhythmic drugs and catheter ablation for the prevention of recurrent ventricular tachycardia in patients with implantable cardioverter-defibrillators: A systematic review and meta-analysis of randomized controlled trials. <i>Heart Rhythm.</i> 2016; <b>13</b>(7): 1552–9. <a target=xrefwindow id=d21594e2045 href="http://www.ncbi.nlm.nih.gov/pubmed/26961297">PubMed Abstract </a> | <a target=xrefwindow id=d21594e2048 href="http://dx.doi.org/10.1016/j.hrthm.2016.03.004">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726210190">F1000 Recommendation</a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725272447"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21594e2061 class=n-a></a>Daubert JP, Zareba W, Cannom DS, <i> et al.</i>: Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact. <i>J Am Coll Cardiol.</i> 2008; <b>51</b>(14): 1357–65. <a target=xrefwindow id=d21594e2072 href="http://www.ncbi.nlm.nih.gov/pubmed/18387436">PubMed Abstract </a> | <a target=xrefwindow id=d21594e2075 href="http://dx.doi.org/10.1016/j.jacc.2007.09.073">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725272447">F1000 Recommendation</a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/720832424"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21594e2089 class=n-a></a>Sweeney MO, Sherfesee L, DeGroot PJ, <i> et al.</i>: Differences in effects of electrical therapy type for ventricular arrhythmias on mortality in implantable cardioverter-defibrillator patients. <i>Heart Rhythm.</i> 2010; <b>7</b>(3): 353–60. <a target=xrefwindow id=d21594e2100 href="http://www.ncbi.nlm.nih.gov/pubmed/20185109">PubMed Abstract </a> | <a target=xrefwindow id=d21594e2103 href="http://dx.doi.org/10.1016/j.hrthm.2009.11.027">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/720832424">F1000 Recommendation</a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a name=d21594e2116 class=n-a></a>Dev S, Peterson PN, Wang Y, <i> et al.</i>: Prevalence, correlates, and temporal trends in antiarrhythmic drug use at discharge after implantable cardioverter defibrillator placement (from the National Cardiovascular Data Registry [NCDR]). <i>Am J Cardiol.</i> 2014; <b>113</b>(2): 314–20. <a target=xrefwindow id=d21594e2127 href="http://www.ncbi.nlm.nih.gov/pubmed/24216126">PubMed Abstract </a> | <a target=xrefwindow id=d21594e2130 href="http://dx.doi.org/10.1016/j.amjcard.2013.09.023">Publisher Full Text </a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a name=d21594e2139 class=n-a></a>Palaniswamy C, Kolte D, Harikrishnan P, <i> et al.</i>: Catheter ablation of postinfarction ventricular tachycardia: ten-year trends in utilization, in-hospital complications, and in-hospital mortality in the United States. <i>Heart Rhythm.</i> 2014; <b>11</b>(11): 2056–63. <a target=xrefwindow id=d21594e2150 href="http://www.ncbi.nlm.nih.gov/pubmed/25016150">PubMed Abstract </a> | <a target=xrefwindow id=d21594e2153 href="http://dx.doi.org/10.1016/j.hrthm.2014.07.012">Publisher Full Text </a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1643957"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21594e2162 class=n-a></a>Kuck KH, Schaumann A, Eckardt L, <i> et al.</i>: Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial. <i>Lancet.</i> 2010; <b>375</b>(9708): 31–40. <a target=xrefwindow id=d21594e2173 href="http://www.ncbi.nlm.nih.gov/pubmed/20109864">PubMed Abstract </a> | <a target=xrefwindow id=d21594e2176 href="http://dx.doi.org/10.1016/S0140-6736(09)61755-4">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1643957">F1000 Recommendation</a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a name=d21594e2189 class=n-a></a>Aliot EM, Stevenson WG, Almendral-Garrote JM, <i> et al.</i>: EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias: developed in a partnership with the European Heart Rhythm Association (EHRA), a Registered Branch of the European Society of Cardiology (ESC), and the Heart Rhythm Society (HRS); in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA). <i>Europace.</i> 2009; <b>11</b>(6): 771–817. <a target=xrefwindow id=d21594e2200 href="http://www.ncbi.nlm.nih.gov/pubmed/19443434">PubMed Abstract </a> | <a target=xrefwindow id=d21594e2203 href="http://dx.doi.org/10.1093/europace/eup098">Publisher Full Text </a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726122471"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21594e2212 class=n-a></a>Liang JJ, Santangeli P, Callans DJ: Long-term Outcomes of Ventricular Tachycardia Ablation in Different Types of Structural Heart Disease. <i>Arrhythm Electrophysiol Rev.</i> 2015; <b>4</b>(3): 177–83. <a target=xrefwindow id=d21594e2220 href="http://www.ncbi.nlm.nih.gov/pubmed/26835122">PubMed Abstract </a> | <a target=xrefwindow id=d21594e2223 href="http://dx.doi.org/10.15420/aer.2015.4.3.177">Publisher Full Text </a> | <a target=xrefwindow id=d21594e2226 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4732176">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726122471">F1000 Recommendation</a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a name=d21594e2240 class=n-a></a>Peck KY, Lim YZ, Hopper I, <i> et al.</i>: Medical therapy versus implantable cardioverter -defibrillator in preventing sudden cardiac death in patients with left ventricular systolic dysfunction and heart failure: a meta-analysis of &gt; 35,000 patients. <i>Int J Cardiol.</i> 2014; <b>173</b>(2): 197–203. <a target=xrefwindow id=d21594e2251 href="http://www.ncbi.nlm.nih.gov/pubmed/24636548">PubMed Abstract </a> | <a target=xrefwindow id=d21594e2254 href="http://dx.doi.org/10.1016/j.ijcard.2014.02.014">Publisher Full Text </a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725312666"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21594e2263 class=n-a></a>Zeidan-Shwiri T, Yang Y, Lashevsky I, <i> et al.</i>: Magnetic resonance estimates of the extent and heterogeneity of scar tissue in ICD patients with ischemic cardiomyopathy predict ventricular arrhythmia. <i>Heart Rhythm.</i> 2015; <b>12</b>(4): 802–8. <a target=xrefwindow id=d21594e2274 href="http://www.ncbi.nlm.nih.gov/pubmed/25583153">PubMed Abstract </a> | <a target=xrefwindow id=d21594e2277 href="http://dx.doi.org/10.1016/j.hrthm.2015.01.007">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725312666">F1000 Recommendation</a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a name=d21594e2290 class=n-a></a>Piers SR, Tao Q, van Huls van Taxis CF, <i> et al.</i>: Contrast-enhanced MRI-derived scar patterns and associated ventricular tachycardias in nonischemic cardiomyopathy: implications for the ablation strategy. <i>Circ Arrhythm Electrophysiol.</i> 2013; <b>6</b>(5): 875–83. <a target=xrefwindow id=d21594e2301 href="http://www.ncbi.nlm.nih.gov/pubmed/24036134">PubMed Abstract </a> | <a target=xrefwindow id=d21594e2304 href="http://dx.doi.org/10.1161/CIRCEP.113.000537">Publisher Full Text </a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a name=d21594e2313 class=n-a></a>Piers SR, Tao Q, de Riva Silva M, <i> et al.</i>: CMR-based identification of critical isthmus sites of ischemic and nonischemic ventricular tachycardia. <i>JACC Cardiovasc Imaging.</i> 2014; <b>7</b>(8): 774–84. <a target=xrefwindow id=d21594e2324 href="http://www.ncbi.nlm.nih.gov/pubmed/25051947">PubMed Abstract </a> | <a target=xrefwindow id=d21594e2327 href="http://dx.doi.org/10.1016/j.jcmg.2014.03.013">Publisher Full Text </a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726161099"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21594e2336 class=n-a></a>Esposito A, Palmisano A, Antunes S, <i> et al.</i>: Cardiac CT With Delayed Enhancement in the Characterization of Ventricular Tachycardia Structural Substrate: Relationship Between CT-Segmented Scar and Electro-Anatomic Mapping. <i>JACC Cardiovasc Imaging.</i> 2016; <b>9</b>(7): 822–32. <a target=xrefwindow id=d21594e2347 href="http://www.ncbi.nlm.nih.gov/pubmed/26897692">PubMed Abstract </a> | <a target=xrefwindow id=d21594e2350 href="http://dx.doi.org/10.1016/j.jcmg.2015.10.024">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726161099">F1000 Recommendation</a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725635884"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21594e2363 class=n-a></a>Acosta J, Fernández-Armenta J, Penela D, <i> et al.</i>: Infarct transmurality as a criterion for first-line endo-epicardial substrate-guided ventricular tachycardia ablation in ischemic cardiomyopathy. <i>Heart Rhythm.</i> 2016; <b>13</b>(1): 85–95. <a target=xrefwindow id=d21594e2374 href="http://www.ncbi.nlm.nih.gov/pubmed/26165946">PubMed Abstract </a> | <a target=xrefwindow id=d21594e2377 href="http://dx.doi.org/10.1016/j.hrthm.2015.07.010">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725635884">F1000 Recommendation</a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a name=d21594e2391 class=n-a></a>Dixit S, Han Y: Cardiac imaging to define infarct transmurality and guide ventricular tachycardia ablation strategy in patients with ischemic cardiomyopathy. <i>Heart Rhythm.</i> 2016; <b>13</b>(1): 96–7. <a target=xrefwindow id=d21594e2399 href="http://www.ncbi.nlm.nih.gov/pubmed/26253037">PubMed Abstract </a> | <a target=xrefwindow id=d21594e2402 href="http://dx.doi.org/10.1016/j.hrthm.2015.08.002">Publisher Full Text </a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a name=d21594e2411 class=n-a></a>Ashikaga H, Arevalo H, Vadakkumpadan F, <i> et al.</i>: Feasibility of image-based simulation to estimate ablation target in human ventricular arrhythmia. <i>Heart Rhythm.</i> 2013; <b>10</b>(8): 1109–16. <a target=xrefwindow id=d21594e2422 href="http://www.ncbi.nlm.nih.gov/pubmed/23608593">PubMed Abstract </a> | <a target=xrefwindow id=d21594e2425 href="http://dx.doi.org/10.1016/j.hrthm.2013.04.015">Publisher Full Text </a> | <a target=xrefwindow id=d21594e2429 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3735782">Free Full Text </a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725451610"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21594e2438 class=n-a></a>Sakamoto N, Sato N, Oikawa K, <i> et al.</i>: Late gadolinium enhancement of cardiac magnetic resonance imaging indicates abnormalities of time-domain T-wave alternans in hypertrophic cardiomyopathy with ventricular tachycardia. <i>Heart Rhythm.</i> 2015; <b>12</b>(8): 1747–55. <a target=xrefwindow id=d21594e2449 href="http://www.ncbi.nlm.nih.gov/pubmed/25916568">PubMed Abstract </a> | <a target=xrefwindow id=d21594e2452 href="http://dx.doi.org/10.1016/j.hrthm.2015.04.028">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725451610">F1000 Recommendation</a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726259146"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21594e2465 class=n-a></a>Chopra H, Arangalage D, Bouleti C, <i> et al.</i>: Prognostic value of the infarct- and non-infarct like patterns and cardiovascular magnetic resonance parameters on long-term outcome of patients after acute myocarditis. <i>Int J Cardiol.</i> 2016; <b>212</b>: 63–9. <a target=xrefwindow id=d21594e2476 href="http://www.ncbi.nlm.nih.gov/pubmed/27035605">PubMed Abstract </a> | <a target=xrefwindow id=d21594e2479 href="http://dx.doi.org/10.1016/j.ijcard.2016.03.004">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726259146">F1000 Recommendation</a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727167771"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21594e2492 class=n-a></a>Corrado D, Link MS, Calkins H: Arrhythmogenic Right Ventricular Cardiomyopathy. <i>N Engl J Med.</i> 2017; <b>376</b>(1): 61–72. <a target=xrefwindow id=d21594e2500 href="http://www.ncbi.nlm.nih.gov/pubmed/28052233">PubMed Abstract </a> | <a target=xrefwindow id=d21594e2503 href="http://dx.doi.org/10.1056/NEJMra1509267">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727167771">F1000 Recommendation</a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a name=d21594e2516 class=n-a></a>Macias C, Nakamura K, Tung R, <i> et al.</i>: Importance Of Delayed Enhanced Cardiac MRI In Idiopathic RVOT-VT: Differentiating Mimics Including Early Stage ARVC And Cardiac Sarcoidosis. <i>J Atr Fibrillation.</i> 2014; <b>7</b>(4): 1097. <a target=xrefwindow id=d21594e2527 href="http://www.ncbi.nlm.nih.gov/pubmed/27957128">PubMed Abstract </a> | <a target=xrefwindow id=d21594e2530 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5135196">Free Full Text </a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725411340"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21594e2540 class=n-a></a>Sasaki T, Calkins H, Miller CF, <i> et al.</i>: New insight into scar-related ventricular tachycardia circuits in ischemic cardiomyopathy: Fat deposition after myocardial infarction on computed tomography--A pilot study. <i>Heart Rhythm.</i> 2015; <b>12</b>(7): 1508–18. <a target=xrefwindow id=d21594e2551 href="http://www.ncbi.nlm.nih.gov/pubmed/25814415">PubMed Abstract </a> | <a target=xrefwindow id=d21594e2554 href="http://dx.doi.org/10.1016/j.hrthm.2015.03.041">Publisher Full Text </a> | <a target=xrefwindow id=d21594e2558 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4485604">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725411340">F1000 Recommendation</a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725721118"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21594e2571 class=n-a></a>Tung R, Bauer B, Schelbert H, <i> et al.</i>: Incidence of abnormal positron emission tomography in patients with unexplained cardiomyopathy and ventricular arrhythmias: The potential role of occult inflammation in arrhythmogenesis. <i>Heart Rhythm.</i> 2015; <b>12</b>(12): 2488–98. <a target=xrefwindow id=d21594e2582 href="http://www.ncbi.nlm.nih.gov/pubmed/26272522">PubMed Abstract </a> | <a target=xrefwindow id=d21594e2585 href="http://dx.doi.org/10.1016/j.hrthm.2015.08.014">Publisher Full Text </a> | <a target=xrefwindow id=d21594e2589 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4656080">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725721118">F1000 Recommendation</a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a name=d21594e2602 class=n-a></a>Jamil-Copley S, Bokan R, Kojodjojo P, <i> et al.</i>: Noninvasive electrocardiographic mapping to guide ablation of outflow tract ventricular arrhythmias. <i>Heart Rhythm.</i> 2014; <b>11</b>(4): 587–94. <a target=xrefwindow id=d21594e2613 href="http://www.ncbi.nlm.nih.gov/pubmed/24440381">PubMed Abstract </a> | <a target=xrefwindow id=d21594e2616 href="http://dx.doi.org/10.1016/j.hrthm.2014.01.013">Publisher Full Text </a> | <a target=xrefwindow id=d21594e2620 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4067940">Free Full Text </a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a name=d21594e2629 class=n-a></a>Arenal A, Perez-David E, Avila P, <i> et al.</i>: Noninvasive identification of epicardial ventricular tachycardia substrate by magnetic resonance-based signal intensity mapping. <i>Heart Rhythm.</i> 2014; <b>11</b>(8): 1456–64. <a target=xrefwindow id=d21594e2640 href="http://www.ncbi.nlm.nih.gov/pubmed/24747421">PubMed Abstract </a> | <a target=xrefwindow id=d21594e2643 href="http://dx.doi.org/10.1016/j.hrthm.2014.04.022">Publisher Full Text </a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a name=d21594e2652 class=n-a></a>Yokokawa M, Jung DY, Joseph KK, <i> et al.</i>: Computerized analysis of the 12-lead electrocardiogram to identify epicardial ventricular tachycardia exit sites. <i>Heart Rhythm.</i> 2014; <b>11</b>(11): 1966–73. <a target=xrefwindow id=d21594e2663 href="http://www.ncbi.nlm.nih.gov/pubmed/24993461">PubMed Abstract </a> | <a target=xrefwindow id=d21594e2666 href="http://dx.doi.org/10.1016/j.hrthm.2014.06.036">Publisher Full Text </a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a name=d21594e2675 class=n-a></a>Fernandez-Falgueras A, Sarquella-Brugada G, Brugada J, <i> et al.</i>: Cardiac Channelopathies and Sudden Death: Recent Clinical and Genetic Advances. <i>Biology (Basel).</i> 2017; <b>6</b>(1): pii: E7. <a target=xrefwindow id=d21594e2686 href="http://www.ncbi.nlm.nih.gov/pubmed/28146053">PubMed Abstract </a> | <a target=xrefwindow id=d21594e2689 href="http://dx.doi.org/10.3390/biology6010007">Publisher Full Text </a> | <a target=xrefwindow id=d21594e2693 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5372000">Free Full Text </a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a name=d21594e2703 class=n-a></a>Maron BJ, Zipes DP, Kovacs RJ: Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Preamble, Principles, and General Considerations: A Scientific Statement From the American Heart Association and American College of Cardiology. <i>J Am Coll Cardiol.</i> 2015; <b>66</b>(21): 2343–9. <a target=xrefwindow id=d21594e2711 href="http://www.ncbi.nlm.nih.gov/pubmed/26542655">PubMed Abstract </a> | <a target=xrefwindow id=d21594e2714 href="http://dx.doi.org/10.1016/j.jacc.2015.09.032">Publisher Full Text </a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a name=d21594e2723 class=n-a></a>Ostby SA, Bos JM, Owen HJ, <i> et al.</i>: Competitive Sports Participation in Patients With Catecholaminergic Polymorphic Ventricular Tachycardia: A Single Center’s Early Experience. <i>JACC: Clinical Electrophysiology.</i> 2016; <b>2</b>(3): 253–62. <a target=xrefwindow id=d21594e2734 href="http://dx.doi.org/10.1016/j.jacep.2016.01.020">Publisher Full Text </a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a name=d21594e2743 class=n-a></a>Nademanee K, Hocini M, Haissaguerre M: Epicardial substrate ablation for Brugada syndrome. <i>Heart Rhythm.</i> 2017; <b>14</b>(3): 457–61. <a target=xrefwindow id=d21594e2751 href="http://www.ncbi.nlm.nih.gov/pubmed/27979714">PubMed Abstract </a> | <a target=xrefwindow id=d21594e2754 href="http://dx.doi.org/10.1016/j.hrthm.2016.12.001">Publisher Full Text </a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a name=d21594e2763 class=n-a></a>Zhang P, Tung R, Zhang Z, <i> et al.</i>: Characterization of the epicardial substrate for catheter ablation of Brugada syndrome. <i>Heart Rhythm.</i> 2016; <b>13</b>(11): 2151–8. <a target=xrefwindow id=d21594e2774 href="http://www.ncbi.nlm.nih.gov/pubmed/27453126">PubMed Abstract </a> | <a target=xrefwindow id=d21594e2777 href="http://dx.doi.org/10.1016/j.hrthm.2016.07.025">Publisher Full Text </a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a name=d21594e2786 class=n-a></a>Connolly SJ, Dorian P, Roberts RS, <i> et al.</i>: Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial. <i>JAMA.</i> 2006; <b>295</b>(2): 165–71. <a target=xrefwindow id=d21594e2797 href="http://www.ncbi.nlm.nih.gov/pubmed/16403928">PubMed Abstract </a> | <a target=xrefwindow id=d21594e2800 href="http://dx.doi.org/10.1001/jama.295.2.165">Publisher Full Text </a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727737448"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21594e2809 class=n-a></a>Schleifer JW, Sorajja D, Shen WK: Advances in the pharmacologic treatment of ventricular arrhythmias. <i>Expert Opin Pharmacother.</i> 2015; <b>16</b>(17): 2637–51. <a target=xrefwindow id=d21594e2817 href="http://www.ncbi.nlm.nih.gov/pubmed/26513538">PubMed Abstract </a> | <a target=xrefwindow id=d21594e2820 href="http://dx.doi.org/10.1517/14656566.2015.1100170">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727737448">F1000 Recommendation</a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726263935"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21594e2834 class=n-a></a>Kudenchuk PJ, Brown SP, Daya M, <i> et al.</i>: Amiodarone, Lidocaine, or Placebo in Out-of-Hospital Cardiac Arrest. <i>N Engl J Med.</i> 2016; <b>374</b>(18): 1711–22. <a target=xrefwindow id=d21594e2845 href="http://www.ncbi.nlm.nih.gov/pubmed/27043165">PubMed Abstract </a> | <a target=xrefwindow id=d21594e2848 href="http://dx.doi.org/10.1056/NEJMoa1514204">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726263935">F1000 Recommendation</a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726470648"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21594e2861 class=n-a></a>Ortiz M, Martin A, Arribas F, <i> et al.</i>: Randomized comparison of intravenous procainamide vs. intravenous amiodarone for the acute treatment of tolerated wide QRS tachycardia: the PROCAMIO study. <i>Eur Heart J.</i> 2017; <b>38</b>(17): 1329–35. <a target=xrefwindow id=d21594e2872 href="http://www.ncbi.nlm.nih.gov/pubmed/27354046">PubMed Abstract </a> | <a target=xrefwindow id=d21594e2875 href="http://dx.doi.org/10.1093/eurheartj/ehw230">Publisher Full Text </a> | <a target=xrefwindow id=d21594e2879 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5410924">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726470648">F1000 Recommendation</a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726334804"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21594e2892 class=n-a></a>Sapp JL, Wells GA, Parkash R, <i> et al.</i>: Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs. <i>N Engl J Med.</i> 2016; <b>375</b>(2): 111–21. <a target=xrefwindow id=d21594e2903 href="http://www.ncbi.nlm.nih.gov/pubmed/27149033">PubMed Abstract </a> | <a target=xrefwindow id=d21594e2906 href="http://dx.doi.org/10.1056/NEJMoa1513614">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726334804">F1000 Recommendation</a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a name=d21594e2919 class=n-a></a>Liang JJ, Yang W, Santangeli P, <i> et al.</i>: Amiodarone Discontinuation or Dose Reduction Following Catheter Ablation for Ventricular Tachycardia in Structural Heart Disease. <i>JACC: Clinical Electrophysiology.</i> 2017; <b>3</b>(5): 503–11. <a target=xrefwindow id=d21594e2930 href="http://dx.doi.org/10.1016/j.jacep.2016.11.005">Publisher Full Text </a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726688697"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21594e2939 class=n-a></a>Tagami T, Matsui H, Ishinokami S, <i> et al.</i>: Amiodarone or nifekalant upon hospital arrival for refractory ventricular fibrillation after out-of-hospital cardiac arrest. <i>Resuscitation.</i> 2016; <b>109</b>: 127–32. <a target=xrefwindow id=d21594e2950 href="http://www.ncbi.nlm.nih.gov/pubmed/27568110">PubMed Abstract </a> | <a target=xrefwindow id=d21594e2953 href="http://dx.doi.org/10.1016/j.resuscitation.2016.08.017">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726688697">F1000 Recommendation</a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a name=d21594e2966 class=n-a></a>Harayama N, Nihei S, Nagata K, <i> et al.</i>: Comparison of nifekalant and amiodarone for resuscitation of out-of-hospital cardiopulmonary arrest resulting from shock-resistant ventricular fibrillation. <i>J Anesth.</i> 2014; <b>28</b>(4): 587–92. <a target=xrefwindow id=d21594e2977 href="http://www.ncbi.nlm.nih.gov/pubmed/24389941">PubMed Abstract </a> | <a target=xrefwindow id=d21594e2980 href="http://dx.doi.org/10.1007/s00540-013-1775-5">Publisher Full Text </a> | <a target=xrefwindow id=d21594e2984 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4126999">Free Full Text </a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a name=d21594e2994 class=n-a></a>Dorian P, Borggrefe M, Al-Khalidi HR, <i> et al.</i>: Placebo-controlled, randomized clinical trial of azimilide for prevention of ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillator. <i>Circulation.</i> 2004; <b>110</b>(24): 3646–54. <a target=xrefwindow id=d21594e3005 href="http://www.ncbi.nlm.nih.gov/pubmed/15533855">PubMed Abstract </a> | <a target=xrefwindow id=d21594e3008 href="http://dx.doi.org/10.1161/01.CIR.0000149240.98971.A8">Publisher Full Text </a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726683450"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21594e3017 class=n-a></a>Køber L, Thune JJ, Nielsen JC, <i> et al.</i>: Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure. <i>N Engl J Med.</i> 2016; <b>375</b>(13): 1221–30. <a target=xrefwindow id=d21594e3028 href="http://www.ncbi.nlm.nih.gov/pubmed/27571011">PubMed Abstract </a> | <a target=xrefwindow id=d21594e3031 href="http://dx.doi.org/10.1056/NEJMoa1608029">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726683450">F1000 Recommendation</a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a name=d21594e3044 class=n-a></a>Wilkoff BL, Fauchier L, Stiles MK, <i> et al.</i>: 2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing. <i>Heart Rhythm.</i> 2016; <b>13</b>(2): e50–86. <a target=xrefwindow id=d21594e3055 href="http://www.ncbi.nlm.nih.gov/pubmed/26607062">PubMed Abstract </a> | <a target=xrefwindow id=d21594e3058 href="http://dx.doi.org/10.1016/j.hrthm.2015.11.018">Publisher Full Text </a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718326938"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21594e3067 class=n-a></a>Lambiase PD, Barr C, Theuns DA, <i> et al.</i>: Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD Registry. <i>Eur Heart J.</i> 2014; <b>35</b>(25): 1657–65. <a target=xrefwindow id=d21594e3078 href="http://www.ncbi.nlm.nih.gov/pubmed/24670710">PubMed Abstract </a> | <a target=xrefwindow id=d21594e3081 href="http://dx.doi.org/10.1093/eurheartj/ehu112">Publisher Full Text </a> | <a target=xrefwindow id=d21594e3085 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4076663">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718326938">F1000 Recommendation</a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727737449"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21594e3098 class=n-a></a>Burke MC, Gold MR, Knight BP, <i> et al.</i>: Safety and Efficacy of the Totally Subcutaneous Implantable Defibrillator: 2-Year Results From a Pooled Analysis of the IDE Study and EFFORTLESS Registry. <i>J Am Coll Cardiol.</i> 2015; <b>65</b>(16): 1605–15. <a target=xrefwindow id=d21594e3109 href="http://www.ncbi.nlm.nih.gov/pubmed/25908064">PubMed Abstract </a> | <a target=xrefwindow id=d21594e3112 href="http://dx.doi.org/10.1016/j.jacc.2015.02.047">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727737449">F1000 Recommendation</a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726745339"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21594e3125 class=n-a></a>Moore JP, Mondésert B, Lloyd MS, <i> et al.</i>: Clinical Experience With the Subcutaneous Implantable Cardioverter-Defibrillator in Adults With Congenital Heart Disease. <i>Circ Arrhythm Electrophysiol.</i> 2016; <b>9</b>(9): pii: e004338. <a target=xrefwindow id=d21594e3136 href="http://www.ncbi.nlm.nih.gov/pubmed/27635073">PubMed Abstract </a> | <a target=xrefwindow id=d21594e3139 href="http://dx.doi.org/10.1161/CIRCEP.116.004338">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726745339">F1000 Recommendation</a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a name=d21594e3153 class=n-a></a>De Maria E, Cappelli S, Cappato R: Shock efficacy of the entirely subcutaneous defibrillator for termination of spontaneous ventricular fibrillation in Brugada syndrome. <i>Heart Rhythm.</i> 2013; <b>10</b>(12): 1807–9. <a target=xrefwindow id=d21594e3161 href="http://www.ncbi.nlm.nih.gov/pubmed/23933298">PubMed Abstract </a> | <a target=xrefwindow id=d21594e3164 href="http://dx.doi.org/10.1016/j.hrthm.2013.08.008">Publisher Full Text </a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727737450"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21594e3173 class=n-a></a>Maurizi N, Tanini I, Olivotto I, <i> et al.</i>: Effectiveness of subcutaneous implantable cardioverter-defibrillator testing in patients with hypertrophic cardiomyopathy. <i>Int J Cardiol.</i> 2017; <b>231</b>: 115–9. <a target=xrefwindow id=d21594e3184 href="http://www.ncbi.nlm.nih.gov/pubmed/28073660">PubMed Abstract </a> | <a target=xrefwindow id=d21594e3187 href="http://dx.doi.org/10.1016/j.ijcard.2016.12.187">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727737450">F1000 Recommendation</a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/722826652"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21594e3200 class=n-a></a>Gold MR, Theuns DA, Knight BP, <i> et al.</i>: Head-to-head comparison of arrhythmia discrimination performance of subcutaneous and transvenous ICD arrhythmia detection algorithms: the START study. <i>J Cardiovasc Electrophysiol.</i> 2012; <b>23</b>(4): 359–66. <a target=xrefwindow id=d21594e3211 href="http://www.ncbi.nlm.nih.gov/pubmed/22035049">PubMed Abstract </a> | <a target=xrefwindow id=d21594e3214 href="http://dx.doi.org/10.1111/j.1540-8167.2011.02199.x">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/722826652">F1000 Recommendation</a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a name=d21594e3227 class=n-a></a>Olde Nordkamp LR, Knops RE, Bardy GH, <i> et al.</i>: Rationale and design of the PRAETORIAN trial: a Prospective, RAndomizEd comparison of subcuTaneOus and tRansvenous ImplANtable cardioverter-defibrillator therapy. <i>Am Heart J.</i> 2012; <b>163</b>(5): 753–760.e2. <a target=xrefwindow id=d21594e3238 href="http://www.ncbi.nlm.nih.gov/pubmed/22607851">PubMed Abstract </a> | <a target=xrefwindow id=d21594e3241 href="http://dx.doi.org/10.1016/j.ahj.2012.02.012">Publisher Full Text </a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a name=d21594e3250 class=n-a></a>Gold MR, Knops R, Burke MC, <i> et al.</i>: The Design of the Understanding Outcomes with the S-ICD in Primary Prevention Patients with Low EF Study (UNTOUCHED). <i>Pacing Clin Electrophysiol.</i> 2017; <b>40</b>(1): 1–8. <a target=xrefwindow id=d21594e3261 href="http://www.ncbi.nlm.nih.gov/pubmed/27943348">PubMed Abstract </a> | <a target=xrefwindow id=d21594e3264 href="http://dx.doi.org/10.1111/pace.12994">Publisher Full Text </a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a name=d21594e3273 class=n-a></a>Neuzil P, Reddy VY, Merkely B, <i> et al.</i>: Implantable intravascular defibrillator: defibrillation thresholds of an intravascular cardioverter-defibrillator compared with those of a conventional ICD in humans. <i>Heart Rhythm.</i> 2014; <b>11</b>(2): 210–5. <a target=xrefwindow id=d21594e3284 href="http://www.ncbi.nlm.nih.gov/pubmed/24144885">PubMed Abstract </a> | <a target=xrefwindow id=d21594e3287 href="http://dx.doi.org/10.1016/j.hrthm.2013.10.035">Publisher Full Text </a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a name=d21594e3297 class=n-a></a>Mallidi J, Nadkarni GN, Berger RD, <i> et al.</i>: Meta-analysis of catheter ablation as an adjunct to medical therapy for treatment of ventricular tachycardia in patients with structural heart disease. <i>Heart Rhythm.</i> 2011; <b>8</b>(4): 503–10. <a target=xrefwindow id=d21594e3308 href="http://www.ncbi.nlm.nih.gov/pubmed/21147263">PubMed Abstract </a> | <a target=xrefwindow id=d21594e3311 href="http://dx.doi.org/10.1016/j.hrthm.2010.12.015">Publisher Full Text </a> | <a target=xrefwindow id=d21594e3315 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3065522">Free Full Text </a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726268468"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21594e3324 class=n-a></a>Pokorney SD, Friedman DJ, Calkins H, <i> et al.</i>: Catheter ablation of ventricular tachycardia: Lessons learned from past clinical trials and implications for future clinical trials. <i>Heart Rhythm.</i> 2016; <b>13</b>(8): 1748–54. <a target=xrefwindow id=d21594e3335 href="http://www.ncbi.nlm.nih.gov/pubmed/27050910">PubMed Abstract </a> | <a target=xrefwindow id=d21594e3338 href="http://dx.doi.org/10.1016/j.hrthm.2016.04.001">Publisher Full Text </a> | <a target=xrefwindow id=d21594e3342 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5070490">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726268468">F1000 Recommendation</a></span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a name=d21594e3355 class=n-a></a>Stevenson WG, Soejima K: Catheter ablation for ventricular tachycardia. <i>Circulation.</i> 2007; <b>115</b>(21): 2750–60. <a target=xrefwindow id=d21594e3363 href="http://www.ncbi.nlm.nih.gov/pubmed/17533195">PubMed Abstract </a> | <a target=xrefwindow id=d21594e3366 href="http://dx.doi.org/10.1161/CIRCULATIONAHA.106.655720">Publisher Full Text </a></span></li><li><a name=ref-63 class=n-a></a><span class=label>63. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725274025"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21594e3375 class=n-a></a>Proietti R, Essebag V, Beardsall J, <i> et al.</i>: Substrate-guided ablation of haemodynamically tolerated and untolerated ventricular tachycardia in patients with structural heart disease: effect of cardiomyopathy type and acute success on long-term outcome. <i>Europace.</i> 2015; <b>17</b>(3): 461–7. <a target=xrefwindow id=d21594e3386 href="http://www.ncbi.nlm.nih.gov/pubmed/25488957">PubMed Abstract </a> | <a target=xrefwindow id=d21594e3389 href="http://dx.doi.org/10.1093/europace/euu326">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725274025">F1000 Recommendation</a></span></li><li><a name=ref-64 class=n-a></a><span class=label>64. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726048123"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21594e3402 class=n-a></a>Di Biase L, Burkhardt JD, Lakkireddy D, <i> et al.</i>: Ablation of Stable VTs Versus Substrate Ablation in Ischemic Cardiomyopathy: The VISTA Randomized Multicenter Trial. <i>J Am Coll Cardiol.</i> 2015; <b>66</b>(25): 2872–82. <a target=xrefwindow id=d21594e3413 href="http://www.ncbi.nlm.nih.gov/pubmed/26718674">PubMed Abstract </a> | <a target=xrefwindow id=d21594e3416 href="http://dx.doi.org/10.1016/j.jacc.2015.10.026">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726048123">F1000 Recommendation</a></span></li><li><a name=ref-65 class=n-a></a><span class=label>65. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726491738"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21594e3429 class=n-a></a>Kumar S, Romero J, Mehta NK, <i> et al.</i>: Long-term outcomes after catheter ablation of ventricular tachycardia in patients with and without structural heart disease. <i>Heart Rhythm.</i> 2016; <b>13</b>(10): 1957–63. <a target=xrefwindow id=d21594e3440 href="http://www.ncbi.nlm.nih.gov/pubmed/27392945">PubMed Abstract </a> | <a target=xrefwindow id=d21594e3443 href="http://dx.doi.org/10.1016/j.hrthm.2016.07.001">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726491738">F1000 Recommendation</a></span></li><li><a name=ref-66 class=n-a></a><span class=label>66. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725529692"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21594e3457 class=n-a></a>Tung R, Vaseghi M, Frankel DS, <i> et al.</i>: Freedom from recurrent ventricular tachycardia after catheter ablation is associated with improved survival in patients with structural heart disease: An International VT Ablation Center Collaborative Group study. <i>Heart Rhythm.</i> 2015; <b>12</b>(9): 1997–2007. <a target=xrefwindow id=d21594e3468 href="http://www.ncbi.nlm.nih.gov/pubmed/26031376">PubMed Abstract </a> | <a target=xrefwindow id=d21594e3471 href="http://dx.doi.org/10.1016/j.hrthm.2015.05.036">Publisher Full Text </a> | <a target=xrefwindow id=d21594e3475 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4549209">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725529692">F1000 Recommendation</a></span></li><li><a name=ref-67 class=n-a></a><span class=label>67. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726148344"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21594e3488 class=n-a></a>Marchlinski FE, Haffajee CI, Beshai JF, <i> et al.</i>: Long-Term Success of Irrigated Radiofrequency Catheter Ablation of Sustained Ventricular Tachycardia: Post-Approval THERMOCOOL VT Trial. <i>J Am Coll Cardiol.</i> 2016; <b>67</b>(6): 674–83. <a target=xrefwindow id=d21594e3499 href="http://www.ncbi.nlm.nih.gov/pubmed/26868693">PubMed Abstract </a> | <a target=xrefwindow id=d21594e3502 href="http://dx.doi.org/10.1016/j.jacc.2015.11.041">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726148344">F1000 Recommendation</a></span></li><li><a name=ref-68 class=n-a></a><span class=label>68. </span>&nbsp;<span class=citation><a name=d21594e3515 class=n-a></a>Mizuno H, Vergara P, Maccabelli G, <i> et al.</i>: Contact force monitoring for cardiac mapping in patients with ventricular tachycardia. <i>J Cardiovasc Electrophysiol.</i> 2013; <b>24</b>(5): 519–24. <a target=xrefwindow id=d21594e3526 href="http://www.ncbi.nlm.nih.gov/pubmed/23373693">PubMed Abstract </a> | <a target=xrefwindow id=d21594e3529 href="http://dx.doi.org/10.1111/jce.12080">Publisher Full Text </a></span></li><li><a name=ref-69 class=n-a></a><span class=label>69. </span>&nbsp;<span class=citation><a name=d21594e3538 class=n-a></a>Aryana A, d'Avila A: Contact force during VT ablation: vector orientation is key. <i>Circ Arrhythm Electrophysiol.</i> 2014; <b>7</b>(6): 1009–10. <a target=xrefwindow id=d21594e3546 href="http://www.ncbi.nlm.nih.gov/pubmed/25516578">PubMed Abstract </a> | <a target=xrefwindow id=d21594e3549 href="http://dx.doi.org/10.1161/CIRCEP.114.002389">Publisher Full Text </a></span></li><li><a name=ref-70 class=n-a></a><span class=label>70. </span>&nbsp;<span class=citation><a name=d21594e3558 class=n-a></a>Jesel L, Sacher F, Komatsu Y, <i> et al.</i>: Characterization of contact force during endocardial and epicardial ventricular mapping. <i>Circ Arrhythm Electrophysiol.</i> 2014; <b>7</b>(6): 1168–73. <a target=xrefwindow id=d21594e3569 href="http://www.ncbi.nlm.nih.gov/pubmed/25258362">PubMed Abstract </a> | <a target=xrefwindow id=d21594e3572 href="http://dx.doi.org/10.1161/CIRCEP.113.001219">Publisher Full Text </a></span></li><li><a name=ref-71 class=n-a></a><span class=label>71. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727737520"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21594e3581 class=n-a></a>Almendral J, Castellanos E: Epicardial ablation in post-myocardial infarction ventricular tachycardia: could it be one of the missing pieces of the puzzle? <i>Circ Arrhythm Electrophysiol.</i> 2015; <b>8</b>(4): 767–8. <a target=xrefwindow id=d21594e3589 href="http://www.ncbi.nlm.nih.gov/pubmed/26286302">PubMed Abstract </a> | <a target=xrefwindow id=d21594e3592 href="http://dx.doi.org/10.1161/CIRCEP.115.003247">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727737520">F1000 Recommendation</a></span></li><li><a name=ref-72 class=n-a></a><span class=label>72. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727737521"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21594e3606 class=n-a></a>Aryana A, d'Avila A: Epicardial Catheter Ablation of Ventricular Tachycardia. <i>Card Electrophysiol Clin.</i> 2017; <b>9</b>(1): 119–31. <a target=xrefwindow id=d21594e3614 href="http://www.ncbi.nlm.nih.gov/pubmed/28167080">PubMed Abstract </a> | <a target=xrefwindow id=d21594e3617 href="http://dx.doi.org/10.1016/j.ccep.2016.10.009">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727737521">F1000 Recommendation</a></span></li><li><a name=ref-73 class=n-a></a><span class=label>73. </span>&nbsp;<span class=citation><a name=d21594e3630 class=n-a></a>Sauer WH, Steckman DA, Zipse MM, <i> et al.</i>: High-power bipolar ablation for incessant ventricular tachycardia utilizing a deep midmyocardial septal circuit. <i>HeartRhythm Case Rep.</i> 2015; <b>1</b>(6): 397–400. <a target=xrefwindow id=d21594e3641 href="http://www.ncbi.nlm.nih.gov/pubmed/28491595">PubMed Abstract </a> | <a target=xrefwindow id=d21594e3644 href="http://dx.doi.org/10.1016/j.hrcr.2015.01.018">Publisher Full Text </a> | <a target=xrefwindow id=d21594e3648 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5419695">Free Full Text </a></span></li><li><a name=ref-74 class=n-a></a><span class=label>74. </span>&nbsp;<span class=citation><a name=d21594e3657 class=n-a></a>Koruth JS, Dukkipati S, Miller MA, <i> et al.</i>: Bipolar irrigated radiofrequency ablation: a therapeutic option for refractory intramural atrial and ventricular tachycardia circuits. <i>Heart Rhythm.</i> 2012; <b>9</b>(12): 1932–41. <a target=xrefwindow id=d21594e3668 href="http://www.ncbi.nlm.nih.gov/pubmed/22863684">PubMed Abstract </a> | <a target=xrefwindow id=d21594e3671 href="http://dx.doi.org/10.1016/j.hrthm.2012.08.001">Publisher Full Text </a></span></li><li><a name=ref-75 class=n-a></a><span class=label>75. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726214016"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21594e3680 class=n-a></a>Skoda J, Arya A, Garcia F, <i> et al.</i>: Catheter Ablation of Ischemic Ventricular Tachycardia With Remote Magnetic Navigation: STOP-VT Multicenter Trial. <i>J Cardiovasc Electrophysiol.</i> 2016; <b>27</b>(Suppl 1): S29–37. <a target=xrefwindow id=d21594e3691 href="http://www.ncbi.nlm.nih.gov/pubmed/26969220">PubMed Abstract </a> | <a target=xrefwindow id=d21594e3694 href="http://dx.doi.org/10.1111/jce.12910">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726214016">F1000 Recommendation</a></span></li><li><a name=ref-76 class=n-a></a><span class=label>76. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725364880"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21594e3707 class=n-a></a>Choi EK, Nagashima K, Lin KY, <i> et al.</i>: Surgical cryoablation for ventricular tachyarrhythmia arising from the left ventricular outflow tract region. <i>Heart Rhythm.</i> 2015; <b>12</b>(6): 1128–36. <a target=xrefwindow id=d21594e3718 href="http://www.ncbi.nlm.nih.gov/pubmed/25697752">PubMed Abstract </a> | <a target=xrefwindow id=d21594e3721 href="http://dx.doi.org/10.1016/j.hrthm.2015.02.016">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725364880">F1000 Recommendation</a></span></li><li><a name=ref-77 class=n-a></a><span class=label>77. </span>&nbsp;<span class=citation><a name=d21594e3734 class=n-a></a>Sapp JL, Beeckler C, Pike R, <i> et al.</i>: Initial human feasibility of infusion needle catheter ablation for refractory ventricular tachycardia. <i>Circulation.</i> 2013; <b>128</b>(21): 2289–95. <a target=xrefwindow id=d21594e3745 href="http://www.ncbi.nlm.nih.gov/pubmed/24036605">PubMed Abstract </a> | <a target=xrefwindow id=d21594e3748 href="http://dx.doi.org/10.1161/CIRCULATIONAHA.113.003423">Publisher Full Text </a></span></li><li><a name=ref-78 class=n-a></a><span class=label>78. </span>&nbsp;<span class=citation><a name=d21594e3758 class=n-a></a>Gianni C, Mohanty S, Trivedi C, <i> et al.</i>: Alternative Approaches for Ablation of Resistant Ventricular Tachycardia. <i>Card Electrophysiol Clin.</i> 2017; <b>9</b>(1): 93–8. <a target=xrefwindow id=d21594e3769 href="http://www.ncbi.nlm.nih.gov/pubmed/28167089">PubMed Abstract </a> | <a target=xrefwindow id=d21594e3772 href="http://dx.doi.org/10.1016/j.ccep.2016.10.006">Publisher Full Text </a></span></li><li><a name=ref-79 class=n-a></a><span class=label>79. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725286975"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21594e3781 class=n-a></a>Philips B, te Riele AS, Sawant A, <i> et al.</i>: Outcomes and ventricular tachycardia recurrence characteristics after epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy. <i>Heart Rhythm.</i> 2015; <b>12</b>(4): 716–25. <a target=xrefwindow id=d21594e3792 href="http://www.ncbi.nlm.nih.gov/pubmed/25530221">PubMed Abstract </a> | <a target=xrefwindow id=d21594e3795 href="http://dx.doi.org/10.1016/j.hrthm.2014.12.018">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725286975">F1000 Recommendation</a></span></li><li><a name=ref-80 class=n-a></a><span class=label>80. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727737522"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21594e3808 class=n-a></a>Hong JC, Crawford T, Tandri H, <i> et al.</i>: What Is the Role of Cardiac Sympathetic Denervation for Recurrent Ventricular Tachycardia? <i>Curr Treat Options Cardiovasc Med.</i> 2017; <b>19</b>(2): 11. <a target=xrefwindow id=d21594e3819 href="http://www.ncbi.nlm.nih.gov/pubmed/28275941">PubMed Abstract </a> | <a target=xrefwindow id=d21594e3822 href="http://dx.doi.org/10.1007/s11936-017-0512-z">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727737522">F1000 Recommendation</a></span></li><li><a name=ref-81 class=n-a></a><span class=label>81. </span>&nbsp;<span class=citation><a name=d21594e3835 class=n-a></a>Tan AY, Abdi S, Buxton AE, <i> et al.</i>: Percutaneous stellate ganglia block for acute control of refractory ventricular tachycardia. <i>Heart Rhythm.</i> 2012; <b>9</b>(12): 2063–7. <a target=xrefwindow id=d21594e3846 href="http://www.ncbi.nlm.nih.gov/pubmed/22863887">PubMed Abstract </a> | <a target=xrefwindow id=d21594e3849 href="http://dx.doi.org/10.1016/j.hrthm.2012.07.030">Publisher Full Text </a></span></li><li><a name=ref-82 class=n-a></a><span class=label>82. </span>&nbsp;<span class=citation><a name=d21594e3858 class=n-a></a>Vaseghi M, Gima J, Kanaan C, <i> et al.</i>: Cardiac sympathetic denervation in patients with refractory ventricular arrhythmias or electrical storm: intermediate and long-term follow-up. <i>Heart Rhythm.</i> 2014; <b>11</b>(3): 360–6. <a target=xrefwindow id=d21594e3869 href="http://www.ncbi.nlm.nih.gov/pubmed/24291775">PubMed Abstract </a> | <a target=xrefwindow id=d21594e3872 href="http://dx.doi.org/10.1016/j.hrthm.2013.11.028">Publisher Full Text </a> | <a target=xrefwindow id=d21594e3876 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4253031">Free Full Text </a></span></li><li><a name=ref-83 class=n-a></a><span class=label>83. </span>&nbsp;<span class=citation><a name=d21594e3885 class=n-a></a>Cuculich P (Principal Investigator): Phase I/II Study of EP-guided Noninvasive cardiac radioablation for treatment of ventricular tachycardia (ENCORE-VT). <i>Clinicaltrials.gov</i>. NCT02919618. <a target=xrefwindow id=d21594e3890 href="https://clinicaltrials.gov/ct2/show/NCT02919618">Reference Source</a></span></li><li><a name=ref-84 class=n-a></a><span class=label>84. </span>&nbsp;<span class=citation><a name=d21594e3900 class=n-a></a>Loo BW Jr, Soltys SG, Wang L, <i> et al.</i>: Stereotactic ablative radiotherapy for the treatment of refractory cardiac ventricular arrhythmia. <i>Circ Arrhythm Electrophysiol.</i> 2015; <b>8</b>(3): 748–50. <a target=xrefwindow id=d21594e3911 href="http://www.ncbi.nlm.nih.gov/pubmed/26082532">PubMed Abstract </a> | <a target=xrefwindow id=d21594e3914 href="http://dx.doi.org/10.1161/CIRCEP.115.002765">Publisher Full Text </a></span></li><li><a name=ref-85 class=n-a></a><span class=label>85. </span>&nbsp;<span class=citation><a name=d21594e3923 class=n-a></a>Maguire P: CyberHeart’s Cardiac arrhythmia ablation treatment: patients with refractory ventricular tachycardia/fibrillation. <i>Clinicaltrials.gov</i>. NCT02661048. <a target=xrefwindow id=d21594e3928 href="https://clinicaltrials.gov/ct2/show/NCT02661048">Reference Source</a></span></li><li><a name=ref-86 class=n-a></a><span class=label>86. </span>&nbsp;<span class=citation><a name=d21594e3937 class=n-a></a>Stevenson WG: Intramural needle ablation for ablation of recurrent ventricular tachycardia. <i>Clinicaltrials.gov</i>. NCT01791543. <a target=xrefwindow id=d21594e3942 href="https://clinicaltrials.gov/ct2/show/NCT01791543">Reference Source</a></span></li><li><a name=ref-87 class=n-a></a><span class=label>87. </span>&nbsp;<span class=citation><a name=d21594e3951 class=n-a></a>Nguyen DT, Tzou WS, Zheng L, <i> et al.</i>: Enhanced Radiofrequency Ablation With Magnetically Directed Metallic Nanoparticles. <i>Circ Arrhythm Electrophysiol.</i> 2016; <b>9</b>(5): pii: e003820. <a target=xrefwindow id=d21594e3962 href="http://www.ncbi.nlm.nih.gov/pubmed/27162034">PubMed Abstract </a> | <a target=xrefwindow id=d21594e3965 href="http://dx.doi.org/10.1161/CIRCEP.115.003820">Publisher Full Text </a></span></li><li><a name=ref-88 class=n-a></a><span class=label>88. </span>&nbsp;<span class=citation><a name=d21594e3974 class=n-a></a>Klein T, Abdulghani M, Smith M, <i> et al.</i>: Three-dimensional 123I-meta-iodobenzylguanidine cardiac innervation maps to assess substrate and successful ablation sites for ventricular tachycardia: feasibility study for a novel paradigm of innervation imaging. <i>Circ Arrhythm Electrophysiol.</i> 2015; <b>8</b>(3): 583–91. <a target=xrefwindow id=d21594e3985 href="http://www.ncbi.nlm.nih.gov/pubmed/25713216">PubMed Abstract </a> | <a target=xrefwindow id=d21594e3988 href="http://dx.doi.org/10.1161/CIRCEP.114.002105">Publisher Full Text </a></span></li><li><a name=ref-89 class=n-a></a><span class=label>89. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/3882956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d21594e3997 class=n-a></a>Jacobson AF, Senior R, Cerqueira MD, <i> et al.</i>: Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study. <i>J Am Coll Cardiol.</i> 2010; <b>55</b>(20): 2212–21. <a target=xrefwindow id=d21594e4008 href="http://www.ncbi.nlm.nih.gov/pubmed/20188504">PubMed Abstract </a> | <a target=xrefwindow id=d21594e4011 href="http://dx.doi.org/10.1016/j.jacc.2010.01.014">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/3882956">F1000 Recommendation</a></span></li><li><a name=ref-90 class=n-a></a><span class=label>90. </span>&nbsp;<span class=citation><a name=d21594e4025 class=n-a></a>Oster HS, Taccardi B, Lux RL, <i> et al.</i>: Electrocardiographic imaging: Noninvasive characterization of intramural myocardial activation from inverse-reconstructed epicardial potentials and electrograms. <i>Circulation.</i> 1998; <b>97</b>(15): 1496–507. <a target=xrefwindow id=d21594e4036 href="http://www.ncbi.nlm.nih.gov/pubmed/9576431">PubMed Abstract </a> | <a target=xrefwindow id=d21594e4039 href="http://dx.doi.org/10.1161/01.CIR.97.15.1496">Publisher Full Text </a></span></li><li><a name=ref-91 class=n-a></a><span class=label>91. </span>&nbsp;<span class=citation><a name=d21594e4048 class=n-a></a>Zhang J, Sacher F, Hoffmayer K, <i> et al.</i>: Cardiac electrophysiological substrate underlying the ECG phenotype and electrogram abnormalities in Brugada syndrome patients. <i>Circulation.</i> 2015; <b>131</b>(22): 1950–9. <a target=xrefwindow id=d21594e4059 href="http://www.ncbi.nlm.nih.gov/pubmed/25810336">PubMed Abstract </a> | <a target=xrefwindow id=d21594e4062 href="http://dx.doi.org/10.1161/CIRCULATIONAHA.114.013698">Publisher Full Text </a> | <a target=xrefwindow id=d21594e4066 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4452400">Free Full Text </a></span></li><li><a name=ref-92 class=n-a></a><span class=label>92. </span>&nbsp;<span class=citation><a name=d21594e4075 class=n-a></a>Zhang J, Cooper DH, Desouza KA, <i> et al.</i>: Electrophysiologic Scar Substrate in Relation to VT: Noninvasive High-Resolution Mapping and Risk Assessment with ECGI. <i>Pacing Clin Electrophysiol.</i> 2016; <b>39</b>(8): 781–91. <a target=xrefwindow id=d21594e4086 href="http://www.ncbi.nlm.nih.gov/pubmed/27197804">PubMed Abstract </a> | <a target=xrefwindow id=d21594e4089 href="http://dx.doi.org/10.1111/pace.12882">Publisher Full Text </a> | <a target=xrefwindow id=d21594e4093 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4970912">Free Full Text </a></span></li><li><a name=ref-93 class=n-a></a><span class=label>93. </span>&nbsp;<span class=citation><a name=d21594e4102 class=n-a></a>Luther V, Linton NW, Jamil-Copley S, <i> et al.</i>: A Prospective Study of Ripple Mapping the Post-Infarct Ventricular Scar to Guide Substrate Ablation for Ventricular Tachycardia. <i>Circ Arrhythm Electrophysiol.</i> 2016; <b>9</b>(6): pii: e004072. <a target=xrefwindow id=d21594e4113 href="http://www.ncbi.nlm.nih.gov/pubmed/27307519">PubMed Abstract </a> | <a target=xrefwindow id=d21594e4116 href="http://dx.doi.org/10.1161/CIRCEP.116.004072">Publisher Full Text </a></span></li><li><a name=ref-94 class=n-a></a><span class=label>94. </span>&nbsp;<span class=citation><a name=d21594e4125 class=n-a></a>Jamil-Copley S, Vergara P, Carbucicchio C, <i> et al.</i>: Application of ripple mapping to visualize slow conduction channels within the infarct-related left ventricular scar. <i>Circ Arrhythm Electrophysiol.</i> 2015; <b>8</b>(1): 76–86. <a target=xrefwindow id=d21594e4136 href="http://www.ncbi.nlm.nih.gov/pubmed/25527678">PubMed Abstract </a> | <a target=xrefwindow id=d21594e4139 href="http://dx.doi.org/10.1161/CIRCEP.114.001827">Publisher Full Text </a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 29 Jun 2017</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/6-1027/v1&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/6-1027/v1&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Arrhythmia Division, Montefiore Medical Center, Bronx, New York, USA<br/> <sup>2</sup> University of Iowa Hospitals and Clinics, Iowa City, USA<br/> <sup>3</sup> Division of Cardiovascular Medicine, University of Louisville School of Medicine, Louisville, USA<br/> <p> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/6-1027/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 29 Jun 2017, 6:1027 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.11202.1">https://doi.org/10.12688/f1000research.11202.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> © 2017 Batul SA <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=12086 data-id=11202 data-downloads="" data-views="" data-scholar="10.12688/f1000research.11202.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/6-1027/v1/pdf?article_uuid=8bc7d05f-e5bf-4f1b-9ebe-05a6057ff9d7" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.11202.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Batul SA, Olshansky B, Fisher JD and Gopinathannair R. Recent advances in the management of ventricular tachyarrhythmias [version 1; peer review: 2 approved] <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):1027 (<a href="https://doi.org/10.12688/f1000research.11202.1" target=_blank>https://doi.org/10.12688/f1000research.11202.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=11202 id=mobile-track-article-signin-11202 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/11202?target=/articles/6-1027/v1"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=12086 /> <input name=articleId type=hidden value=11202 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Lars Eckardt</strong>, Division of Electrophysiology, Department of Cardiovascular Medicine, , University of Münster, Germany </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Pasquale Santangeli</strong>, Electrophysiology Section, Division of Cardiology, Hospital of the University of Pennsylvania, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 29 Jun 2017</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/6-1027/v1&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/6-1027/v1&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=23850-23772></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=23851-23771></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=2><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/6-1027/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>29 Jun 17</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Lars Eckardt</strong>, Division of Electrophysiology, Department of Cardiovascular Medicine, , University of Münster, Germany </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Pasquale Santangeli</strong>, Electrophysiology Section, Division of Cardiology, Hospital of the University of Pennsylvania, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/6-1027/v1&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/6-1027/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Recent advances in the management of ventricular...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/6-1027/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/6-1027/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/6-1027/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Batul SA et al.');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/6-1027/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/6-1027",
            templates : {
                twitter : "Recent advances in the management of ventricular tachyarrhythmias. Batul SA et al., published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/6-1027/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Recent advances in the management of ventricular tachyarrhythmias", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Recent advances in the management of ventricular tachyarrhythmias", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/11202/12086")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "12086");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "23771": 0,
                           "23772": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "7be41d9a-9256-488c-9551-fe7f9f048013";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-1027.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-1027.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-1027.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/6-1027.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/6-1027.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>